chapter 4 oxybromination -...
TRANSCRIPT
Chapter 4 Oxybromination
72
Section A
Oxybromination of aromatic compounds
4.1. State of art
The classical direct bromination involves the use of potentially hazardous and difficult to
handle molecular bromine [1], sometimes with expensive transition metal-based catalysts [2].
These reactions involve several environmental drawbacks because of the toxic nature of the
reagents and the formation of hydrogen bromide as a byproduct which is corrosive, toxic and
pollutant to the environment. Moreover, while using bromine, only half of the Br atoms are
utilized and the other turns into hydrobromic acid, reducing the atom efficiency by 50%.
Recently, bromination of aromatic compounds has been reported using 1-butyl-3-
methylpyridinium tribromide [3], 2,4,4,6-tetrabromo-2,5-cyclohexadienone [4], Br2/SO2Cl2 [5],
hexamethylenetetramine-bromine [6], (Bmim)Br3 [7], NBS-ammonium acetate [8], NBS-
photochemical [9], KBr-H2O2-titania-pillared zirconium phosphate and titanium phosphates [10],
iso-amyl nitrate/HBr [11], N,N,N’,N’-tetrabromobenzene-1,3-disulfonylamide [12], N-
bromophthalimide [13], alkylbromide-NaH-DMSO [14]. However, many existing bromination
processes do not advance the goal of non-toxic, waste-free chemistry. Therefore, the
development of an efficient, ecofriendly, 100% utilization of bromine and selective reaction for
monobromination of aromatic compounds is still a major challenge in organic synthesis.
In this section of the chapter, bromination of various aromatic compounds in H2O and
MeOH at room temperature has been discussed (Scheme 4.1).
Chapter 4 Oxybromination
73
R
NH4Br, Oxone
MeOH or H2O, r.t.
R
Br
Scheme 4.1. Bromination of aromatic compounds
4.2. General experimental procedure
4.2.1. General information
All chemicals were reagent grade and were used without further purification. 1H NMR
spectra were recorded on a Gemini-200 MHz spectrometer in CDCl3 or DMSO-d6 with TMS as
the internal standard. Mass spectra were recorded on a Finnigan MAT 1020 mass spectrometer
operating at 70 eV. GC was carried out using Shimadzu (GC-14B) instrumentation. Column
chromatography was accomplished using silica gel (Acme, <200 mesh). Spectral data (1H NMR
and MS) of representative products are provided.
4.2.2. General procedure for the bromination of aromatic compounds
To a solution of aromatic compound (2 mmol) in MeOH or H2O (10 mL) were added
NH4Br (2.2 mmol) and oxone (2.2 mmol) and the mixture was stirred at room temperature for
the time shown in Table 4.2 and Table 4.3. After completion (as indicated by TLC), the reaction
mixture was filtered and the solvent evaporated under reduced pressure. The products were
purified by column chromatography over silica gel.
4.3. Results and discussion
4.3.1. Optimization of reaction conditions
Initially, we investigated the oxybromination of resorcinol with ammonium bromide as
the bromine source and oxone as the oxidant, in various solvents. The best results were obtained
with methanol, water or acetonitrile as solvent (Table 4.1). The reaction was complete within 10
Chapter 4 Oxybromination
74
minutes in water, but was less selective toward the para isomer compared to methanol and
acetonitrile. Using methanol, the reaction was complete in 30 minutes and the selectivity for the
para isomer was 97%, whilst the selectivity for the same isomer was 98%, after two hours, when
using acetonitrile as the solvent. Hydrogen peroxide (H2O2) as the oxidant (with acetic acid as
the solvent) gave inferior results to those obtained with oxone (Table 4.1). Furthermore,
ammonium bromide proved to be a superior bromine source compared to potassium bromide
(KBr) with both oxone and hydrogen peroxide as oxidants (Table 4.1).
To establish the general applicability of the NH4Br–oxone system, the bromination of a
number of aromatic compounds was investigated and the results are summarized in Table 4.2
and Table 4.3. The brominated products were identified on the basis of 1H NMR and mass
spectral data and by comparison with literature data [8,15].
This study included activated and inactivated aromatics as well as compounds of
moderate activity. All the reactions were performed at room temperature using equimolar
amounts (1.1 equivalents) of ammonium bromide and oxone and methanol or water as the
solvent. The reactions typically proceeded via selective monobromination, preferentially at the
para position.
Chapter 4 Oxybromination
75
Table 4.1. Optimization of the oxybromination of resorcinola
OH
OH
Br source, Oxidant
Solvent, r.t.
OH
OH
Br
OH
OH
Br
Br
+
1 2 3 Entry Br source
(mmol)
Oxidant
(mmol)
Solvent Time
(min)
Conversion
(%)b
Selectivity (Yield, %)c
2 3
1
2
3
4
5
6
7
8
9
10
11
12
NH4Br
(2)
NH4Br
(2.2)
NH4Br
(2)
NH4Br
(2.2)
NH4Br
(2)
NH4Br
(2.2)
NH4Br
(2)
NH4Br
(2.2)
KBr
(2)
KBr
(2.2)
KBr
(2)
KBr
(2.2)
Oxone
(2.2)
Oxone
(2.2)
Oxone
(2.2)
Oxone
(2.2)
Oxone
(2.2)
Oxone
(2.2)
H2O2
(2.2)
H2O2
(2.2)
Oxone
(2.2)
Oxone
(2.2)
Oxone
(2.2)
Oxone
(2.2)
CH3CN
CH3CN
MeOH
MeOH
H2O
H2O
AcOH
AcOH
CH3CN
CH3CN
MeOH
MeOH
120
120
30
30
10
10
120
120
90
90
60
60
99
99
99
98
99
99
99
94
99
97
99
98
85 (84) 15 (15)
98 (97) 2 (2)
88 (87) 12 (12)
97 (95) 3 (3)
53 (52) 47 (47)
86 (85) 14 (14)
67 (66) 33 (33)
92 (87) 8 (7)
83 (82) 17 (17)
95 (92) 5 (5)
77 (76) 23 (23)
93 (91) 7 (7)
Chapter 4 Oxybromination
76
13
14
15
KBr
(2.2)
KBr
(2)
KBr
(2.2)
Oxone
(2.2)
H2O2
(2.2)
H2O2
(2.2)
H2O
AcOH
AcOH
10
420
270
91
99
95
75 (68) 25 (23)
71 (70) 29 (29)
88 (84) 12 (11)
aReaction conditions: resorcinol (2 mmol), Br source, oxidant, solvent (10 mL), room temperature.
bConversions determined by GC.
cThe products were characterized by
1H NMR spectroscopy, mass spectrometry and quantified by GC.
4.3.2. Bromination of aromatic compounds using H2O as a solvent
Bromination of 2-methylresorcinol gave the para isomer, with respect to the hydroxy
groups, as the major product along with the dibrominated product (Table 4.2, entry 2). 1,3,5-
Trihydroxybenzene also provided the monobrominated derivative as the major product, along
with the dibrominated product (Table 4.2, entry 3). Reaction of 2-methoxyphenol gave the para
isomer (4-bromo-2-methoxyphenol) and 5-bromo-2-methoxyphenol in the ratio 40:56 (Table 4.2,
entry 4). 2-Hydroxynaphthalene furnished 1-bromo-2-hydroxynaphthalene after three hours with
66% yield (Table 4.2, entry 5). Interesting results were obtained with alkyl substituted aromatic
compounds which afforded ring-brominated products in water (Table 4.2, entries 6–10). 2-
Methylnaphthalene rendered 1-bromo-2-methylnaphthalene as the only product in water (Table
4.2, entry 6). In the case of isobutylbenzene α-brominated derivative, (1-bromo-2-
methylpropyl)benzene, was formed in water (Table 4.2, entry 8). Bromination of alkyl benzenes
required longer reaction times compared to those of the hydroxy benzene derivatives.
Bromobenzene, nitrobenzene and naphthalene proved unreactive even after prolonged
reaction times (Table 4.2, entries 11–13). Thus, less reactive aromatic substrates did not undergo
nuclear bromination under these conditions. The ability of the substrate to undergo the
Chapter 4 Oxybromination
77
bromination reaction would appear to depend on the electron density of the aromatic ring. The
results indicate that bromination favors formation of para-substituted products over the
corresponding ortho derivatives.
Table 4.2. Bromination of aromatic compounds using NH4Br and oxone in H2Oa
R
NH4Br, Oxone
H2O, r.t.
R
Br
Entry Substrate Time Product (Yield, %)b
1
2
3
4
5
OH
OH
OH
OH
OH
OHOH
OH
OMe
OH
10 min
25 min
5 min
45 min
3 h
OH
OH
Br
OH
OH
Br
Br
(85) (14)
OH
OH
Br
OH
OH
Br
Br
(66) (29)
OH
OH
Br
OH
OH
OH
Br
Br
OH
(75) (24)
OH
Br
OMe
OH
Br
OMe
(40) (56)
OH
Br
(66)
Chapter 4 Oxybromination
78
6
7
8
9
10
11
12
13
CH
3
Br
NO2
24 h
4 h
2 h
4 h
40 min
24 h
24 h
24 h
Br
(75)
Br
(66)
Br
(53)
Br
(72)
Br
(61)
-
-
-
aSubstrate (2 mmol), NH4Br (2.2 mmol), Oxone (2.2 mmol), H2O (10 ml), Room temperature.
bGC yield.
Chapter 4 Oxybromination
79
4.3.3. Bromination of aromatic compounds using MeOH as a solvent
Bromination of 2-methylresorcinol gave the para isomer, with respect to the hydroxy
groups, as the major product in methanol along with a small amount of the corresponding
dibrominated product (Table 4.3, entry 2). 1,3,5-Trihydroxybenzene also furnished the
monobrominated derivative as the major product, along with a small amount of the
corresponding dibrominated product, in methanol (Table 4.3, entry 3). Reaction of 2-
methoxyphenol in methanol afforded the para isomer (4-bromo-2-methoxyphenol) and 5-bromo-
2-methoxyphenol in the ratio 77:22 (Table 4.3, entry 4). 2-Hydroxynaphthalene provided 1-
bromo-2-hydroxynaphthalene in methanol, the reaction was completed in 45 minutes and the
yield was 99% (Table 4.3, entry 5). Interesting results were obtained with alkyl substituted
aromatic compounds which gave ring-brominated products in methanol (Table 4.3, entries 6–10).
Monobromination occurred exclusively at the para-position relative to the alkyl group in
methanol as solvent (Table 4.3, entries 7–10). 2-Methylnaphthalene yielded 1-bromo-2-
methylnaphthalene as the only product (Table 4.3, entry 6). Different results were obtained in the
case of isobutylbenzene depending on the solvent. The ring-brominated product was obtained in
methanol (Table 4.3, entry 8), whilst the α-brominated derivative (1-bromo-2-
methylpropyl)benzene, was formed in water (Table 4.2, entry 8). Bromination of alkyl benzenes
required longer reaction times compared to those of the hydroxy benzene derivatives. This
method was also suitable for the bromination of 4-hydroxycoumarin (Table 4.3, entry 11). In this
case, bromination took place at C-3 to give the corresponding product in very high yield.
Bromobenzene, nitrobenzene and naphthalene proved unreactive even after prolonged reaction
times (Table 4.3, entries 12–14). Thus, less reactive aromatic substrates did not undergo nuclear
bromination under these conditions. The ability of the substrate to undergo the bromination
Chapter 4 Oxybromination
80
reaction would appear to depend on the electron density of the aromatic ring. The results indicate
that bromination favors formation of para-substituted products over the corresponding ortho
derivatives.
Table 4.3. Bromination of aromatic compounds using NH4Br and oxone in MeOHa
R
NH4Br, Oxone
MeOH, r.t.
R
Br
Entry Substrate Time Product (Yield, %)b
1
2
3
4
5
OH
OH
OH
OH
OH
OHOH
OH
OMe
OH
30 min
30 min
30 min
3 h
45 min
OH
OH
Br
OH
OH
Br
Br
(95) (3)
OH
OH
Br
OH
OH
Br
Br
(90) (9)
OH
OH
Br
OH
OH
OH
Br
Br
OH
(90) (9)
OH
Br
OMe
OH
Br
OMe
(77) (22)
OH
Br
(99)
Chapter 4 Oxybromination
81
6
7
8
9
10
11
12
13
14
CH
3
O
OH
O Br
NO
2
24 h
18 h
3 h
3 h
3 h
45 min
24 h
24 h
24 h
Br
(80)
Br
(99)
Br
(92)
Br
(99)
Br
(85)
O
OH
O
Br
(98)
-
-
-
aSubstrate (2 mmol), NH4Br (2.2 mmol), Oxone (2.2 mmol), MeOH (10 ml), Room temperature.
bGC yield.
Chapter 4 Oxybromination
82
Methyl (-CH3) and methylene (-CH2-) group attached aromatic compounds gave good
yields of ring brominated products in MeOH (Table 5.3, entries 6-10). An unexpected result was
observed when iso-propyl group attached aromatic compounds (cumene and p-cymeme)
subjected to bromination using the same reagent system. Instead of ring bromination, ether
formation was observed with cumene and p-cymene (Scheme 4.2).
OMe
OMe
NH4Br (1.1 equiv)
Oxone (1.1 equiv)
MeOH (10 ml) 6 h, r.t.
68%
47%
Scheme 4.2. Reaction of iso-propyl substituted aromatics with NH4Br and oxone in MeOH
4.3.4. Mechanism
The bromination of aromatic compounds with ammonium bromide in the presence of
oxone proceeds according to the stoichiometry shown in Scheme 4.3. It is believed that the
reaction proceeds via the formation of hypobromous acid (HOBr) which is very unstable due to
its pronounced ionic nature and is thus more reactive toward aromatic nuclei.
ArH+NH4Br+2KHSO5.KHSO4.K2SO4
ArBr+NH4OH+K2S2O8.KHSO4.K2SO4+H2O
Scheme 4.3. Reaction stoichiometry
Chapter 4 Oxybromination
83
4.4. Spectral data
4-Bromo-1,3-dihydroxybenzene [16]
OH
OH
Br
1H NMR (200 MHz, CDCl3): δ 4.81 (bs, 1 H, OH), 5.49 (bs, 1 H, OH), 6.37 (dd, 1 H, J = 8.5, 2.7
Hz, ArH), 6.50 (d, 1 H, J = 2.7 Hz, ArH), 7.25 (d, 1 H, J = 8.5 Hz, ArH).
13C NMR (50 MHz, CDCl3): δ 98.4, 103.5, 110.1, 132.4, 154.1, 156.9.
2,4-Dibromo-5-hydroxyphenol [16]
OH
OH
Br
Br
1H NMR (200 MHz, CDCl3): δ 5.42 (s, 2 H, OH), 6.76 (s, 1 H, ArH), 7.61 (s, 1 H, ArH).
13C NMR (50 MHz, CDCl3): δ 100.1, 103.6, 133.1, 153.9.
2-Methoxy-4-bromophenol [17]
OH
Br
OMe
1H NMR (200 MHz, CDCl3): δ 3.83 (s, 3 H), 6.70 (d, 1 H, J = 7.92 Hz), 6.83-6.90 (m, 2 H), 8.3
(bs, 1 H).
13C NMR (50 MHz, CDCl3): δ 56.2, 111.7, 114.3, 116.0, 124.2, 144.9, 147.4.
5-Bromo-2-methoxyphenol [18]
Chapter 4 Oxybromination
84
OH
OMe
Br
1H NMR (200 MHz, CDCl3): δ 3.87 (s, 3 H), 6.71 (d, 1 H, J = 8.6 Hz), 6.97 (dd, 1 H, J = 8.6,
2.41 Hz), 7.07 (d, 1 H, J = 2.4 Hz).
13C NMR (50 MHz, CDCl3): δ 56.6, 112.4, 113.8, 118.3, 123.3, 146.4, 147.0.
1-Bromo-2-naphthol [19]
OH
Br
1H NMR (200 MHz, CDCl3): δ 7.23 (d, 1 H, J = 9.4 Hz), 7.29 (t, 1 H, J = 7.05 Hz), 7.48 (t, 1 H,
J = 8.62 Hz), 7.64 (d, 1 H, J = 8.62), 7.71 (d, 1 H, J = 7.83 Hz), 8.06 (d, 1 H, J = 8.6 Hz), 9.83
(bs, 1 H).
13C NMR (50 MHz, CDCl3): δ 106.1, 117.1, 124.1, 125.3, 127.8, 128.2, 129.3, 129.7, 132.3,
150.6.
1-Bromo-2-methylnaphthalene [15d]
Br
1H NMR (200 MHz, CDCl3): δ 2.61 (s, 3 H), 7.29 (d, 1 H, J = 8.3 Hz), 7.4 (ddd, 1 H, J = 7.9,
7.1, 0.9 Hz), 7.52 (ddd, 1 H, J = 8.5, 6.8, 1.1 Hz), 7.64 (d, 1 H, J = 8.3 Hz,), 7.72 (d, 1 H, J = 8.5
Hz), 8.25 (d, 1 H, J = 8.5 Hz).
MS (EI): m/z (%) = 222 [M+,81
Br] (19), 220 [M+,79
Br] (19), 141 (100).
1-Bromo-2,4-dimethylbenzene [20]
Chapter 4 Oxybromination
85
Br
1H NMR (200 MHz, CDCl3): δ 2.26 (s, 3 H), 2.34 (s, 3 H), 6.80 (d, 1 H, J = 8.05 Hz), 6.99 (s, 1
H), 7.34 (d, 1 H, J = 8.05 Hz)
13C NMR (50 MHz, CDCl3): δ 20.8, 22.7, 121.5, 128.2, 131.7, 132.0, 137.0, 137.4.
(1-Bromo-2-methylpropyl)benzene [15f]
Br
1H NMR (200 MHz, CDCl3): δ 0.82 (d, 3 H, J = 6.6 Hz), 1.08 (d, 3 H, J = 6.6 Hz), 2.20-2.36 (m,
1 H), 4.65 (d, 1 H, J = 8.3 Hz), 7.15-7.35 (m, 5 H).
MS (EI): m/z (%) = 214 [M+,81
Br] (12), 212 [M+,79
Br] (12), 133 [M+ – Br] (67), 91 [PhCH2+]
(100).
1-Bromo-4-isobutylbenzene [15e]
Br
1H NMR (200 MHz, CDCl3): δ 0.90 (d, 6 H, J = 6.6 Hz), 1.80-1.91 (m, 1 H), 2.45 (d, 2 H, J =
7.3 Hz), 7.09 (d, 2 H, J = 7.3 Hz), 7.20 (d, 2 H, J = 7.3 Hz).
MS (EI): m/z (%) = 214 [M+,81
Br] (32), 212 [M+,79
Br] (32), 169 [M+ – 43] (100), 91 [M
+ – 121]
(27).
Bromomesitylene [21]
Chapter 4 Oxybromination
86
Br
1H NMR (200 MHz, CDCl3): δ 2.22 (s, 3 H), 2.35 (s, 6 H), 6.83 (s, 2 H).
13C NMR (50 MHz, CDCl3): δ 20.6, 23.6, 124.2, 129, 136.2, 137.8.
MS (EI): m/z (%) = 200 [M+,
81Br] (21), 198 [M
+,
79Br] (21), 119 [M
+ – 79] (100), 91 [M
+ – 107]
(96),
1-bromo-2,4,5-trimethylbenzene [22]
Br
1H NMR (200 MHz, CDCl3): δ 2.16 (s, 3 H), 2.18 (s, 3 H), 2.30 (s, 3 H), 6.93 (s, 1 H), 7.23 (s, 1
H).
3-Bromo-4-hydroxycoumarin [15g]
O
OH
Br
O
1H NMR (200 MHz, DMSO-d6): δ 7.24–7.32 (m, 2 H), 7.54 (t, 1 H, J = 6.3 Hz), 7.96 (d, 1 H, J =
8.4 Hz).
MS (EI): m/z (%) = 242 [M+,
81Br] (23), 240 [M
+,
79Br] (23), 211 (100).
2-Methoxy-2-phenylpropane [23]
Chapter 4 Oxybromination
87
O
1H NMR (200 MHz, CDCl3): δ 1.51 (s, 6 H), 3.05 (s, 3 H), 7.18-7.23 (m, 1 H), 7.27-7.32 (m, 2
H), 7.35-7.39 (m, 2 H).
13C NMR (50 MHz, CDCl3): δ 28.4, 51.1, 77.5, 126.2, 126.9, 128.9, 146.1.
P-(l-Methoxy)-isopropyltolue [24]
O
1H NMR (200 MHz, CDCl3): δ 1.50 (s, 6 H), 2.34 (s, 3 H), 3.02 (s, 3 H), 7.08 (d, 2 H, J = 7.1
Hz), 7.25 (d, 2 H, J = 7.1 Hz).
Chapter 4 Oxybromination
88
4.5. References
1. R. Taylor, Electrophilic Aromatic Substitution; Wiley: Chichester (1990).
2. R. C. Larock, Comprehensive Organic Transformations: a Guide To Functional Group
Preparations; Wiley-VCH: New York (1989) 315.
3. S. P. Borikar, T. Daniel, V. Paul, Tetrahedron Lett., 50 (2009) 1007.
4. N. Gupta, G. L. Kad, Synth. Commun., 37 (2007) 3421.
5. J. M. Gnaim, R. A. Sheldon, Tetrahedron Lett., 46 (2005) 4465.
6. M. M. Heravi, N. Abdolhosseini, H. A. Oskooie, Tetrahedron Lett., 46 (2005) 8959.
7. Z. G. Le, Z. C. Chen, Y. Hu, Q. G. Zheng, Chin. Chem. Lett., 16 (2005) 1007.
8. B. Das, K. Venkateswarlu, A. Majhi, V. Siddaiah, K. R. Reddy, J. Mol. Catal. A: Chem.,
267 (2007) 30.
9. P. K. Chhattise, A. V. Ramaswamy, S. B. Waghmode, Tetrahedron Lett., 49 (2008) 189.
10. D. P. Das, K. Parida, Catal. Commun., 7 (2006) 68.
11. L. Gavara, T. Boisse, B. Rigo, J. P. Henichart, Tetrahedron Lett., 64 (2008) 4999.
12. R. G. Vaghei, H. Jalili, Synthesis, (2005) 1099.
13. A. Khazaei, A. A. Mahesh, V. R. Safi, J. Chin. Chem. Soc., 52 (2005) 559.
14. M. J. Guo, L. Varady, D. Fokas, C. Baldino, L. Yu, Tetrahedron Lett., 47 (2006) 3889.
15. (a) Z.-G. Le, Z.-C. Chen, Y. Hu, Chin. J. Chem., 23 (2005) 1537. (b) P. Bovicelli, E.
Mincione, R. Antonioletti, R. Bernini, M. Colombari, Synth. Commun., 31 (2001) 2955.
(c) C. Venkatachalapathy, K. Pitchumani, Tetrahedron, 53 (1997) 2581. (d) A.
Podgorsek, S. Stavber, J. Iskra, M. Zupan, Tetrahedron, 65 (2009) 4429. (e) L. Jin, Y.
Zhao, L. Zhu, H. Zhang, A. Lei, Adv. Synth. Catal., 351 (2009) 630. (f) B. Meynhardt, U.
Luening, C. Wolff, C. Naether, Eur. J. Org. Chem., 9 (1999) 2327. (g) B. Talapatra, S. K.
Chapter 4 Oxybromination
89
Mandal, K. Biswas, R. Chakrabarti, S. K. Talapatra, J. Ind. Chem. Soc., 78 (2001) 765.
16. K. Kotaro, M. Toshiyuki, H. Toshikazu, Tetrahedron Lett., 51 (2010) 340.
17. L. Menini, L. A. Parreira, E. V. Gusevskaya, Tetrahedron Lett., 48 (2007) 6401.
18. A. S. Paraskar, A. Sudalai, Tetrahedron, 62 (2006) 4907.
19. K. Raju, K. Kulangiappar, M. A. Kulandainathan, U. Uma, R. Malini, A. Muthukumaran,
Tetrahedron Lett., 47 (2006) 4581.
20. F. Habib, I. Nasser, K. Somayeh, G. Arash, G. Atefeh, Adv. Synth. Catal., 351 (2009)
1925.
21. S. Fergus, S. J. Eustace, A. F. Hegarty, J. Org. Chem., 69 (2004) 4663.
22. R. Wasylishen, T. Schaefer, R. Schwenk, Can. J. Chem., 48 (1970) 2885.
23. J. A. Murphy, T. A. Khan, S. Zhou, D. W. Thomson, M. Mahesh, Angew. Chem. Int. Ed.,
44 (2005) 1356.
24. B. Isidoro, T. Marcial, Tetrahedron, 48 (1992) 9967.
Chapter 4 Oxybromination
90
Section B
Oxybromination of carbonyl compounds
4.6. State of art
The most commonly used reagents for α-bromination of ketones include molecular
bromine [1], N-bromosuccinimide (NBS) [2] and cupric bromide [3]. Recently, various methods
have been reported using NBS-NH4OAc [4], NBS-photochemical [5], NBS-PTSA [6], NBS-
silica supported sodium hydrogen sulfate [7], NBS-Amberlyst-15 [8], NBS-Lewis acids [9],
NBS-ionic liquids [10], MgBr2-(hydroxy(tosyloxy)iodo)benzene-MW [11], N-methylpyrrolidin-
2-one hydrotribromide (MPHT) [12], (CH3)3SiBr-KNO3 [13], BDMS [14] and NaBr [15].
Reagents used for the bromination of unsymmetrical acyclic ketones are NBS-NH4OAc [4],
NBS-photochemical [5] and NBS-PTSA [6] and all these methods provide a mixture of 1-bromo
(terminal) and 3-bromo ketones with predominant formation of 3-bromo product. Gaudry and
Marquet reported the selective terminal bromination of unsymmetrical acyclic ketone using
elemental bromine [16].
From the green chemistry point of view the use of elemental bromine has several
environmental drawbacks. The handling of liquid bromine, due to its hazardous nature, is
troublesome and special equipment and care is needed for the transfer of these materials in large
scale. Though all these methods provide good yields, most of them suffer from one or more
disadvantages such as long reaction times, harsh reaction conditions, use of hazardous chemicals
and cumbersome work-up procedures. The use of NBS is a better alternative for molecular
bromine, which does not produce HBr in this reaction; but it is expensive and generates organic
waste. Furthermore, most of these methods generally employ strongly acidic or basic conditions
and accompany undesirable formation of α,α-dibrominated products in significant amount.
Chapter 4 Oxybromination
91
Hence, the development of an efficient, eco-friendly, atom-economic (100% with respect to
bromine) and selective procedure for the α-monobromination of ketones remains a major
challenge for synthetic organic chemists.
In this section of the chapter, a highly efficient, environmentally safe and economic
method for selective α-monobromination of aralkyl, cyclic, acyclic, 1,3-diketones and β-keto
esters and α,α-dibromination of 1,3-diketones and β-keto esters without catalyst using
ammonium bromide as a bromine source and oxone as an oxidant has been discussed (Scheme
4.4).
NH4Br,Oxone®
MeOH
O
R
O
O
R Br
O
Br
O O O O
Br
R ArAr
R
R = Alkyl/ ArylRI = Alkyl/ Aryl/ OR
R RI R RI
Scheme 4.4. Bromination of carbonyl compounds
4.7. General experimental procedure
4.7.1. General information
All chemicals used were reagent grade and used as received without further purification.
1H NMR spectra were recorded at 300, 400 and 500 MHz in CDCl3. The chemical shifts () are
reported in ppm units relative to TMS as an internal standard for 1H NMR. Coupling constants
(J) are reported in hertz (Hz) and multiplicities are indicated as follows: s (singlet), bs (broad
singlet), d (doublet), dd (doublet of doublet), t (triplet), m (multiplet). Mass spectra were
recorded under impact (EI) conditions at 70 eV. Column chromatography was carried out using
silica gel (finer than 200 mesh)
Chapter 4 Oxybromination
92
4.7.2. General procedure for monobromination of carbonyl compounds
Oxone (2.2 mmol) was added to the well stirred solution of substrate (2 mmol) and
NH4Br (2.2 mmol) in methanol (10 ml) and the reaction mixture was allowed to stir at room
temperature (or reflux temperature). After completion of the reaction, as monitored by TLC, the
reaction mixture was quenched with aqueous sodium thiosulfate and extracted with ethyl acetate
(3×25 ml). Finally, the combined organic layer was washed with water, dried over anhydrous
sodium sulfate, filtered and removal of solvent in vacuo yielded a crude residue, which was
further purified by column chromatography over silica gel (finer than 200 mesh) to afford pure
products. All the products were identified on the basis of 1H NMR and mass spectral data.
4.7.3. General procedure for dibromination of carbonyl compounds
Oxone (4.4 mmol) was added to the well stirred solution of substrate (2 mmol) and
NH4Br (4.4 mmol) in methanol (10 ml) and the reaction mixture was allowed to stir at room
temperature (or reflux temperature). After completion of the reaction, as monitored by TLC, the
reaction mixture was quenched with aqueous sodium thiosulfate and extracted with ethyl acetate
(3×25 ml). Finally, the combined organic layer was washed with water, dried over anhydrous
sodium sulfate, filtered and removal of solvent in vacuo yielded a crude residue, which was
further purified by column chromatography over silica gel (finer than 200 mesh) to afford pure
products. All the products were identified on the basis of 1H NMR and mass spectral data.
4.7.4. General procedure for dehydrogenation of tetralone and substituted tetralones
Oxone (2.2 mmol) was added to the well stirred solution of substrate (2 mmol) and
NH4Br (4.4 mmol) in DCM (10 ml) and the reaction mixture was allowed to stir at room
temperature (or reflux temperature). After completion of the reaction, as monitored by TLC, the
reaction mixture was quenched with aqueous sodium thiosulfate and extracted with DCM (3×25
Chapter 4 Oxybromination
93
ml). Finally, the combined organic layer was washed with water, dried over anhydrous sodium
sulfate, filtered and removal of solvent in vacuo yielded a crude residue, which was further
purified by column chromatography over silica gel (finer than 200 mesh) to afford pure products.
All the products were identified on the basis of 1H NMR and mass spectral data.
4.8. Results and discussion
4.8.1. Optimization of reaction conditions
Initially, the effect of different solvents on the -bromination of acetophenone was
studied using NH4Br/oxone system (Table 4.4). In methanol at room temperature, the reaction
completed within 7 h to give the -brominated product in 81% yield together with recovery of
starting material. The reaction in CH3CN, H2O gave less than 15% yield after 7 h and in case of
other solvents (DCM, CHCl3, CCl4, hexane, EtOH, ether and THF) the yields were negligible.
Among the solvents used, methanol appeared to be the most suitable in terms of maximum yield.
Chapter 4 Oxybromination
94
Table 4.4. α-Bromination of acetophenone: Effect of solventa
O O
BrNH4Br, Oxone
Solvent
1a
Entry Solvent NH4Br Oxone Yield (%)b
1
2
3
4
5
6
7
8
9
10
11
MeOH
CH3CN
H2O
DCM
CHCl3
CCl4
Hexane
EtOH
Ether
THF
MeOH
2.2
,,
,,
,,
,,
,,
,,
,,
,,
,,
,,
2.2
,,
,,
,,
,,
,,
,,
,,
,,
,,
1.1
81
12
13
-
-
-
-
-
-
-
33
a Acetophenone (2 mmol), Solvent (10 ml), Room temperature, 7 h.
b GC yield.
4.8.2. Bromination of aralkyl ketone
With the optimized conditions in hand, a variety of aralkyl ketones (acetophenone,
substituted acetophenones, acetonaphthone and substituted acetonaphthones) were subjected to
the bromination reaction to test the generality of this method and the results are summarized in
Table 4.5. All the reactions were performed using 2 mmol of substrate with 2.2 mmol of NH4Br
and 2.2 mmol of oxone in 10 ml methanol at room temperature (or reflux temperature).
Chapter 4 Oxybromination
95
It is interesting to mention the effect of reaction temperature on course of bromination,
high yields are obtained at reflux temperature in short reaction time compared to room
temperature. In order to determine the influence of the substitution on aromatic ring on the
reaction path with this reagent system, we studied the reaction with different substitutions on
phenyl ring of acetophenone and acetonaphthones. Presence of highly activating groups (Table
4.5, entries 17, 18 and 22) on phenyl ring favours nuclear bromination, whilst moderately
activating and deactivating groups favours the -bromination (Table 4.5, entries 2-13). Strong
electron-withdrawing groups (Table 4.5, entries 14 and 15) present on phenyl ring gave -
brominated product, along with substantial amount of -bromo dimethyl ketals. Propiophenone
provided the -brominated product with this reagent system, but yield was less even after longer
reaction time (Table 4.5, entry 19). 2-Hydroxy-1,4-naphthoquinone showed good reactivity with
this reagent system and furnished 3-bromo-2-hydroxy-1,4-naphthoquinone (1x) in high yield
within short reaction time (Table 4.5, entry 23).
Chapter 4 Oxybromination
96
Table 4.5. Bromination of aralkyl ketones using NH4Br and oxonea
Entry Substrate Time Product Yield (%)
b
1
2
3
4
5
6
7
8
O
O
O
O
O
Et
O
Br
O
Br
O
Br
7 hc
15 mind
26 hc
2.5 hd
24 hc
40 mind
6 hc
2.5 hd
7 hc
1.5 hd
48 hc
4 hd
48 hc
2 hd
48 hc
1.5 hd
O
Br
1a
O
Br
1b
O
Br
1c
O
Br
1d
O
Et
Br
1e
O
Br
Br
1f
O
Br
Br
1g
O
Br
Br
1h
81
97
92
91
84
96
63
94
54
86
42
56
37 (28)e
73
37
98
Chapter 4 Oxybromination
97
9
10
11
12
13
14
15
16
O
Cl
O
Cl
O
F
O
F
O
F
O
NO2
O
O2N
O
NC
48 hc
3 hd
47 hc
2 hd
24 hc
2 hd
24 hc
2 hd
44 hc
1.3 hd
48 hc
3 hd
24 hc
1.5 hd
48 hc
16 hd
O
Cl
Br
1i O
Cl
Br
1j O
Br
F 1k
O
Br
F 1l
O
Br
F 1m
O
NO2
Br
1n
O
Br
O2N
1o
O
NC
Br
1p
50
73
49
87
81
85
39 (34)e
83
89
97
14 (16)e
46 (14)e
8 (12)e
21 (34)e
38
35 (6)e
Chapter 4 Oxybromination
98
17
18
19
20
21
22
23
O
OH
O
NH2
O
O
O
O
O
O
OH
O
4.5 hc
1.5 hd
1 hc
5 mind
26 hc
7.5 hd
24 hc
1.25 hd
24 hc
20 mind
40 minc
10 mind
3 hc
15 mind
O
OH
Br
1q
O
NH2
Br
1s
O
Br
1t O
Br
1u
O
Br
1v
O
Br
O
1w
O
OH
O
Br
1x
61 (26)f
48 (28)f
93
83
10
58
39
87
60
97
97
94
98
98
a Reaction conditions : Substrate (2 mmol), NH4Br (2.2 mmol), Oxone (2.2 mmol), Methanol (10 ml), Room or
Reflux temperature. b The products were characterized by
1H NMR, Mass spectra and quantified by GC.
c Room temperature.
d Reflux temperature.
e -bromo dimethyl ketal.
f 3-bromo-2-hydroxyacetophenone (1r).
Chapter 4 Oxybromination
99
4.8.3. Bromination of cyclic and acyclic ketones
Further, we studied the bromination of cyclic and acyclic ketones under similar reaction
conditions and results are summarized in Table 4.6. Cyclic ketones are reacted well under the
present reaction condition to furnish the corresponding -bromo ketone in good to excellent
yields, except 5-methoxy and 7-methoxytetralone. 5-Methoxytetralone afforded the respective
ring brominated product (2e) selectively and 7-methoxy-1-tetralone at room temperature forms
the corresponding -brominated (2f) and ring brominated (2g) products in the ratio of 17: 42 in
2.5 h and the same reaction at reflux temperature afforded a 42: 18 ratio within 1 h.
Interesting results were observed when unsymmetrical acyclic ketones subjected to the
bromination with this reagent system. On contrary to the earlier reports [8-10], bromination took
place at less substituted α-position predominantly (Table 4.6, entries 7-11).
Chapter 4 Oxybromination
100
Table 4.6. Bromination of various cyclic and acyclic ketones using NH4Br and oxonea
Entry Substrate Time Products (Yield (%))
b
1
2
3
4
5
6
7
8
O
O
O
O
O
OMe
O
MeO
O
O
2 hc
30 mind
6 hc
20 mind
28 hc
2 hd
6 hc
20 mind
2 hc
20 mind
2.5 hc
1 hd
8 hc
7 hc
50 mind
OBr
(65)(80)
2a
O
Br(92)(98)
2b
O
Br(77)(77)
2c O
Br(79)(95)
2d OBr
OMe
(90)(87)
2e
O
BrMeO(17)(42)
O
MeO
Br
(42)(18)
2f 2g
O
Br (80)
O
Br
(09)
2h 2i
O
Br(90)(85)
O
Br
-(06)
2j 2k
Chapter 4 Oxybromination
101
9
10
11
O
Ph
O
C4H9
O
C6H13
5 hc
30 mind
9 hc
1 hd
7 hc
20 mind
O
BrPh
(65)(71)
O
Br
Ph(10)(21)
2l 2m
(62)(55)
(37)(44)
O
Br
C4H9
O
Br
C4H9
2n 2o
(71)(76)
(28)(23)
O
BrC6H13
O
Br
C6H13
2p 2q
a Substrate (2 mmol), NH4Br (2.2 mmol), Oxone (2.2 mmol), Methanol (10 ml).
b The products were characterized by
1H NMR, Mass spectra and quantified by GC.
c Room temperature.
d Reflux temperature.
4.8.4. Bromination of 1,3-diketones and -keto esters
Finally, we investigated the bromination of 1,3-dicarbonyl compounds under similar
reaction conditions. A variety of -unsubstituted 1,3-diketones and -keto esters were -mono
brominated and ,-dibrominated using NH4Br and oxone with excellent yields (Table 4.7,
entries 1-5). Similarly, -substituted--keto esters underwent -bromination smoothly under
similar conditions and afforded the corresponding -brominated product in high yields (Table
4.7, entries 6-8).
Chapter 4 Oxybromination
102
Table 4.7. Bromination of 1,3-dicarbonyl compounds using NH4Br and oxone
Entry Substrate Time Products (Yield (%))a
1
2
3
4
.
5
6
7
8
O O
Ph Ph
O
O
O
O
O
O
O
O
Ph
O
O
O
Ph
O
O
O
O
O
O
Ph
O
OO
40 minb
3 hc
1 hb
40 mind
3 hb
30 mind
35 minb
30 mind
30 minb
3 hc
9 hb
5 hb
30 minb
O O
Ph Ph
Br
O O
Ph Ph
Br Br
(94) -
-(90)
3a 3b O
O
Br
O
O
Br
Br
(80)
-
(10)(95)
3c 3d
O
O
O
Br
(75) -
O
O
O
BrBr
(24)(94)
3e 3f
O
O
O
Br
Ph(81) -
O
O
O
BrBr
Ph
(18)(96)
3g 3h O
O
O
Br
Ph(90) -
O
O
O
BrBr
Ph
(09)(94)
3i 3j
O
O
O
Br(70)
3k
O
O
O
Ph
Br(87)
3l
O
OO
Br (95)
3m
a The products were characterized by 1H NMR, Mass spectra and quantified by GC. b Substrate (2 mmol), NH4Br (2.2 mmol), Oxone (2.2 mmol), Methanol (10 ml), Room temperature. c Substrate (2 mmol), NH4Br (4.4 mmol), Oxone (4.4 mmol), Methanol (10 ml), Reflux
temperature. d Room temperature.
Chapter 4 Oxybromination
103
4.8.5. Dehydrogenation of tetralone and substituted tetralones
Different results were observed in case of tetralone depending on the solvent. Reaction of
tetralone with NH4Br and oxone was tested in different chlorinated and non-chlorinated solvents
(Table 4.8). In non-chlorinated solvents like methanol, water, acetone, ethanol, iso-propanol and
ether selectively -brominated product (4a) was observed (Table 4.8, entries 1-6). In case of
chlorinated solvents like DCM, CHCl3, CCl4 and DCE along with -brominated product (4a),
dehydrogenated product i.e. 1-naphthol (4b) was also formed (Table 4.8, entries 7-10). The
highest yield of -brominated product (4a) was obtained in MeOH, whilst the corresponding
dehydrogenated product i.e. 1-naphthol (4b), was formed in DCM, 1 equivalent of tetralone with
1.1equivalent of NH4Br and 1.1equivalent of oxone in DCM yielded 65% of 4b, with 2.2
equivalents of NH4Br yielded 90% of 4b (Table 4.8, entry 20).
With the optimized conditions in hand, a variety of substituted tetralones were subjected
to the dehydrogenation reaction to test the generality of this method and the results are
summarized in Scheme 4.5. In case of 5,7-dimethyltetralone and 2-methyltetralone the
dehydrogenated product was formed in 31% and 27% respectively.
Chapter 4 Oxybromination
104
Table 4.8. Reaction of tetralone with NH4Br and oxone: Variation of solventsa
O O
Br
OH
+
4a 4b
NH4Br, Oxone
Solvent
Entry Solvent NH4Br
(mmol)
Oxone
(mmol)
Time (h) Yield (%)b
4a 4b
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
MeOH
H2O
Acetone
EtOH
i-PrOH
Ether
DCM
CHCl3
CCl4
DCE
MeOH
,,
,,
DCM
,,
,,
,,
,,
2.2
2.2
2.2
2.2
2.2
2.2
2.2
2.2
2.2
2.2
2.2
,,
4.4
-
0.2
0.55
1.1
1.65
2.2
2.2
2.2
2.2
2.2
2.2
2.2
2.2
2.2
2.2
-
0.2
4.4
2.2
2.2
,,
2.2
,,
6
6
24
24
24
24
24
24
48
24
6
,,
20c
24
,,
,,
,,
,,
93 -
37 -
13 -
53 -
34 -
20 -
- 65
35 18
11 -
- 40
- -
10 -
71 (28)e -
- -
09 -
- -
- 17
17 43
Chapter 4 Oxybromination
105
19
20
21
,,
,,
,,
2.2
4.4
,,
4.4
2.2
,,
,,
,,
,,d
06 65
- 90
- -
a Tetralone (2 mmol), Solvent (10 ml), Room temperature.
b GC yield.
c At reflux temperature.
d At 0
oC.
e α,α-Dibromotetralone
RNH4Br,Oxone®
DCM+ +
4 R = H, RI = H, RII = H 90 - -5 R = H, RI = Me, RII = Me 31 8 176 R = Me, RI = H, RII = H 27 - 8
7 8 9
Br
OH
RI
RIIO
R
RI
RIIOH
R
RI
RIIO
Br
RI
RII
Scheme 4.5. Aromatization of tetralones
4.8.6. Mechanism
We propose a plausible reaction mechanism for the -bromination of ketones as shown in
Scheme 4.6. It is assumed that oxidation of bromide ion by peroxymonosulfate ion could give
the hypobromite ion, which in turn reacts with ketones to afford -brominated ketones.
HSO5- + Br-
OH
O
Br
O+
H
O
Br
- H2O
OH
HO-Br+
HO-Br+ + SO42-
R
R
R
R Scheme 4.6. Plausible reaction mechanism
Chapter 4 Oxybromination
106
4.9. Spectral data
2-Bromo-1-phenylethanone (1a) [17]
m.p. 49-51 °C
1H NMR (300 MHz, CDCl3): δ 4.40 (s, 2 H), 7.42-7.49 (m, 2 H), 7.54-7.6 (m, 1 H), 7.91-8.00
(m, 2 H).
MS (EI): m/z (%) = 200 [M+,
81Br] (13), 198 [M
+,
79Br] (13), 105 (100), 91 (67), 77 (90).
2-Bromo-1-(2-methylphenyl)ethanone (1b) [31]
1H NMR (300 MHz, CDCl3): δ 2.52 (s, 3 H), 4.34 (s, 2 H), 7.20-7.30 (m, 2 H), 7.40 (t, 1 H, J =
8.3 Hz), 7.66 (d, 1 H, J = 7.36 Hz).
2-Bromo-1-(3-methylphenyl)ethanone (1c) [38]
1H NMR (300 MHz, CDCl3): δ 2.44 (s, 3 H), 4.36 (s, 2 H), 7.32-7.40 (m, 2 H), 7.72-7.78 (m, 2
H).
2-Bromo-1-(4-methylphenyl)ethanone (1d) [17]
m.p. 51-53 °C
1H NMR (300 MHz, CDCl3): δ 2.42 (s, 3 H), 4.34 (s, 2 H), 7.26 (d, 2 H, J = 8.3 Hz), 7.86 (d, 2
H, J = 8.3 Hz).
MS (EI): m/z (%) = 214 [M+,
81Br] (12), 212 [M
+,
79Br] (12), 119 (100), 105 (32), 91 (79), 77
(27), 65 (71).
2-Bromo-1-(4-ethylphenyl)ethanone (1e) [18]
1H NMR (300 MHz, CDCl3): δ 1.25 (t, 3 H, J = 7.55 Hz), 2.72 (q, 2 H, J = 7.55 Hz), 4.35 (s, 2
H), 7.28 (d, 2 H, J = 8.3 Hz), 7.88 (d, 2 H, J = 8.3 Hz).
2-Bromo-1-(4-bromophenyl)ethanone (1h) [17]
m.p. 109-111 °C
Chapter 4 Oxybromination
107
1H NMR (300 MHz, CDCl3): δ 4.34 (s, 2 H), 7.62 (d, 2 H, J = 8.4 Hz), 7.85 (d, 2 H, J = 8.4 Hz).
2-Bromo-1-(3-chlorophenyl)ethanone (1j) [19]
m.p. 39-42 °C
1H NMR (300 MHz, CDCl3): δ 4.35 (s, 2 H), 7.42 (t, 1 H, J = 7.93 Hz), 7.56 (d, 1 H, J = 8.30
Hz), 7.84 (d, 1 H, J = 7.74 Hz), 7.94 (s, 1 H).
2-Bromo-1-(2-fluorophenyl)ethanone (1k) [20]
1H NMR (300 MHz, CDCl3): δ 4.40 (s, 2 H), 7.17 (m, 1 H), 7.3-7.5 (m, 2 H), 7.81 (m, 1 H).
2-Bromo-1-(3-fluorophenyl)ethanone (1l) [39]
1H NMR (300 MHz, CDCl3): δ 4.35 (s, 2 H), 7.30 (m, 1 H), 7.46 (m, 1 H), 7.66 (m, 1 H), 7.76
(m, 1 H).
2-Bromo-1-(4-fluorophenyl)ethanone (1m) [19]
m.p. 45-47 °C
1H NMR (300 MHz, CDCl3): δ 4.33 (s, 2 H), 7.10-7.20 (m, 2 H), 7.95-8.05 (m, 2 H).
2-Bromo-1-(4-cyanophenyl)ethanone (1p) [21]
m.p. 90-93 °C
1H NMR (300 MHz, CDCl3): δ 3.95 (s, 2 H), 7.74 (d, 2 H, J = 8.49 Hz), 8.12 (d, 2 H, J = 8.49
Hz).
1-(5-Bromo-2-hydroxyphenyl)ethanone (1q) [22]
m.p. 60-61 °C
1H NMR (300 MHz, CDCl3): δ 2.62 (s, 3 H), 6.87 (d, 1 H, J = 8.87 Hz), 7.52 (dd, 1 H, J = 2.26,
8.87 Hz), 7.78 (d, 1 H, J = 2.26 Hz), 12.06 (s, 1 H).
1-(3-Bromo-2-hydroxyphenyl)ethanone (1r) [23]
Chapter 4 Oxybromination
108
1H NMR (300 MHz, CDCl3): δ 2.65 (s, 3 H), 6.77 (t, 1 H, J = 8.3 Hz), 7.65-7.73 (m, 2 H), 12.84
(s, 1 H).
1-(2-Amino-5-Bromophenyl)ethanone (1s) [24]
m.p. 84-85 °C
1H NMR (300 MHz, CDCl3): δ 2.55 (s, 3 H), 6.28 (bs, 2 H), 6.51 (d, 1 H, J = 9.06 Hz), 7.28 (dd,
1 H, J = 2.26, 9.06 Hz), 7.74 (d, 1 H, J = 2.26 Hz).
2-Bromo-1-phenylpropan-1-one (1t) [25]
1H NMR (300 MHz, CDCl3): δ 1.90 (d, 3 H, J = 6.04 Hz), 5.24 (q, 1 H, J = 6.04 Hz), 7.46 (t, 2
H, J = 7.55 Hz), 7.56 (t, 1 H, J = 6.79 Hz), 8.00 (d, 2 H, J = 8.3 Hz).
MS (EI): m/z (%) = 214 [M+,
81Br] (46), 212 [M
+,
79Br] (46), 105 (100), 77 (38), 51 (16).
2-Bromo-1-(1-naphthyl)ethanone (1u) [32]
1H NMR (300 MHz, CDCl3): δ 4.48 (s, 2 H), 7.40-7.63 (m, 3 H), 7.80-7.90 (m, 2 H), 7.96 (d, 1
H, J = 8.12 Hz), 8.64 (d, 1 H, J = 8.49 Hz).
2-Bromo-1-(2-naphthyl)ethanone (1v) [26]
m.p. 82-84 °C
1H NMR (300 MHz, CDCl3): δ 4.49 (s, 2 H), 7.50-7.63 (m, 2 H), 7.82-8.03 (m, 4 H), 8.47 (s, 1
H).
5-Bromo-6-methoxy-2-acetonaphthone (1w) [37]
m.p. 126-128 °C
1H NMR (300 MHz, CDCl3): δ 2.68 (s, 3 H), 4.06 (s, 3 H), 7.33 (d, 1 H, J = 9.06 Hz), 7.92 (d, 1
H, J = 9.06 Hz), 8.02 (dd, 1 H, J = 1.7, 9.06 Hz), 8.19 (d, 1 H, J = 8.87 Hz), 8.36 (s, 1 H).
2-Bromocycloheptanone (2a) [17]
Chapter 4 Oxybromination
109
1H NMR (300 MHz, CDCl3): δ 1.3-1.84 (m, 5 H), 1.86-2.12 (m, 3 H), 2.28-2.52 (m, 2 H), 2.8-
2.94 (m, 1 H), 4.30 (dd, 1 H, J = 5.28, 9.44 Hz).
2-Bromo-3,4-dihydro-2H-naphthalen-1-one (2b) [27]
m.p. 40-43 °C
1H NMR (300 MHz, CDCl3) : δ 2.39-2.58 (m, 2 H), 2.89 (dt, 1 H, J = 4.15, 16.99 Hz), 3.25-3.40
(m, 1 H), 4.66 (t, 1 H, J = 4.15 Hz), 7.24 (d, 1 H, J = 7.74 Hz), 7.33 (t, 1 H, J = 7.74 Hz), 7.48
(td, 1 H, J = 1.32, 7.74 Hz), 8.05 (dd, 1 H, J = 0.94, 7.74 Hz).
MS (EI): m/z (%) = 226 [M+,
81Br] (10), 224 [M
+,
79Br] (10), 144 (20), 118 (100), 90 (50).
8-Bromo-5-methoxy-3,4-dihydro-2H-naphthalen-1-one (2e) [28]
m.p. 52-53 °C
1H NMR (300 MHz, CDCl3): δ 2.01-2.15 (m, 2 H), 2.63 (t, 2 H, J = 6.23 Hz), 2.87 (t, 2 H, J =
6.23 Hz), 3.84 (s, 3 H), 6.78 (d, 1 H, J = 8.68 Hz), 7.44 (d, 1 H, J = 8.68 Hz).
MS (EI): m/z (%) = 256 [M+,
81Br] (100), 254 [M
+,
79Br] (100), 226 (72), 198 (50), 76 (27).
2-Bromo-7-methoxy-3,4-dihydro-2H-naphthalen-1-one (2f) [30]
m.p. 80-82 °C
1H NMR (300 MHz, CDCl3) : δ 2.37-2.57 (m, 2 H), 2.82 (dt, 1 H, J = 3.96, 16.8 Hz), 3.19-3.33
(m, 1 H), 3.85 (s, 3 H), 4.65 (t, 1 H, J = 3.96 Hz), 7.05 (dd, 1 H, J = 2.83, 8.49 Hz), 7.15 (d, 1 H,
J = 8.49 Hz), 7.49 (d, 1 H, J = 2.83 Hz).
8-Bromo-7-methoxy-3,4-dihydro-2H-naphthalen-1-one (2g) [29]
m.p. 92-93 °C
1H NMR (300 MHz, CDCl3): δ 2.02-2.13 (m, 2 H), 2.66 (t, 2 H, J = 6.24 Hz), 2.90 (t, 2 H, J =
6.24 Hz), 3.89 (s, 3 H), 6.95 (d, 1 H, J = 8.32 Hz), 7.11 (d, 1 H, J = 8.32 Hz).
MS (EI): m/z (%) = 256 [M+,
81Br] (100), 254 [M
+,
79Br] (100), 226 (60), 198 (72).
Chapter 4 Oxybromination
110
1-Bromobutan-2-one (2h) [33]
1H NMR (500 MHz, CDCl3): δ 1.10 (t, 3 H, J = 6.92 Hz), 2.67 (q, 2 H, J = 6.92 Hz), 3.80 (s, 2
H).
3-Bromobutan-2-one (2i) [33]
1H NMR (500 MHz, CDCl3): δ 1.71 (d, 3 H, J = 6.92 Hz), 2.34 (s, 3 H), 4.32 (q, 1 H, J = 6.92
Hz).
1-Bromo-4-methylpentan-2-one (2j) [7]
1H NMR (500 MHz, CDCl3): δ 0.95 (d, 6 H, J = 6.92 Hz), 2.14-2.22 (m, 1 H), 2.53 (d, 2 H, J =
6.92 Hz), 3.78 (s, 2 H).
1-Bromo-2-nonanone (2p) [17]
1H NMR (500 MHz, CDCl3): δ 0.85-0.92 (m, 4 H), 1.22-1.40 (m, 8 H), 1.56-1.64 (m, 2 H), 2.64
(t, 2 H, J = 6.92 Hz), 3.78 (s, 2 H).
2-Bromo-1,3-diphenylpropane-1,3-dione (3a) [14]
m.p. 89-92 °C
1H NMR (300 MHz, CDCl3): δ 6.40 (s, 1 H), 7.44 (t, 4 H, J = 7.55 Hz), 7.56 (t, 2 H, J = 7.55
Hz), 7.98 (d, 4 H, J = 7.55 Hz).
Ethyl-2-bromo-3-oxobutanoate (3e) [14]
1H NMR (300 MHz, CDCl3): δ 1.33 (t, 3 H, J = 7.17 Hz), 2.43 (s, 3 H), 4.28 (q, 2 H, J = 7.17
Hz), 4.66 (s, 1 H).
Ethyl-2,2-dibromo-3-oxobutanoate (3f) [34]
1H NMR (300 MHz, CDCl3): δ 1.37 (t, 3 H, J = 7.17 Hz), 2.58 (s, 3 H), 4.36 (q, 2 H, J = 7.17
Hz).
Benzyl-2-bromo-3-oxobutanoate (3g) [14]
Chapter 4 Oxybromination
111
1H NMR (300 MHz, CDCl3): δ 2.38 (s, 3 H), 4.70 (s, 1 H), 5.22 (s, 2 H), 7.30-7.38 (m, 5 H).
Benzyl-2,2-dibromo-3-oxobutanoate (3h) [35]
1H NMR (500 MHz, CDCl3): δ 2.51 (s, 3 H), 5.29 (s, 2 H), 7.30-7.38 (m, 5 H).
Ethyl-2-bromo-3-oxo-3-phenylpropanoate (3i) [14]
1H NMR (300 MHz, CDCl3): δ 1.27 (t, 3 H, J = 6.79 Hz), 4.28 (q, 2 H, J = 6.79 Hz), 5.56 (s,
1H), 7.48 (t, 2 H, J = 6.79 Hz), 7.60 (t, 1 H, J = 6.79 Hz), 7.98 (d, 2 H, J = 6.79 Hz).
Ethyl-2,2-dibromo-3-oxo-3-phenylpropanoate (3j) [36]
1H NMR (300 MHz, CDCl3): δ 1.17 (t, 3 H, J = 7.17 Hz), 4.28 (q, 2 H, J = 7.17 Hz), 7.44 (t, 2 H,
J = 6.79 Hz), 7.56 (t, 1 H, J = 6.79 Hz), 8.01 (d, 2 H, J = 6.79 Hz).
Ethyl-2-bromo-2-ethyl-3-oxobutanoate (3k) [14]
1H NMR (300 MHz, CDCl3): δ 1.00 (t, 3 H, J = 6.93 Hz), 1.32 (t, 3 H, J = 6.93 Hz), 2.15-2.29
(m, 2 H), 2.38 (s, 3 H), 4.27 (q, 2 H, J = 6.93 Hz),
1-Bromo-2-oxo-cyclohexanecarboxylic Acid Ethyl Ester (3m) [14]
1H NMR (300 MHz, CDCl3): δ 1.33 (t, 3 H, J = 7.55 Hz), 1.70-2.00 (m, 4 H), 2.16-2.27 (m, 1
H), 2.37-2.48 (m, 1 H), 2.78-3.00 (m, 2 H), 4.29 (q, 2 H, J = 7.55 Hz).
Chapter 4 Oxybromination
112
4.10. References
1. (a) L. A. Bigelow, R. S. Hanslick, In Organic Synthesis; Wiley: New York, (1943)
Collect. Vol. 2, p. 244. (b) K. Hakam, M. Thielmann, T. Thielmann, E. Winterfeldt,
Tetrahedron, 43 (1987) 2035.
2. (a) R. E. Boyd, C. R. Rasmussen, J. B. Press, Synth. Commun., 25 (1995) 1045. (b) S.
Karimi, K. G. Grohmann, J. Org. Chem., 60 (1995) 554. (c) D. P. Curran, E. Bosch, J.
Kaplan, M. N. Comb, J. Org. Chem., 54 (1989) 1826.
3. (a) S. J. Coats, H. H. Wasserman, Tetrahedron Lett., 36 (1995) 7735. (b) A. V. R. Rao,
A. K. Singh, K. M. Reddy, K. R. Kumar, J. Chem. Soc., Perkin Trans.1, (1993) 3171.
4. K. Tanemura, T. Suzuki, Y. Nishida, K. Satsumabayashi, T. Horaguchi, Chem. Commun.,
(2004) 470.
5. S. S. Arbuj, S. B. Waghmode, A. V. Ramaswamy, Tetrahedron Lett., 48 (2007) 1411.
6. I. Pravst, M. Zupan, S. Stavber, Tetrahedron, 64 (2008) 5191.
7. B. Das, K. Venkateswarlu, G. Mahender, I. Mahender, Tetrahedron Lett., 46 (2005)
3041.
8. H. M. Meshram, P. N. Reddy, K. Sadashiv, J. S. Yadav, Tetrahedron Lett., 46 (2005)
623.
9. D. Yang, Y. L. Yan, B. Lui, J. Org. Chem., 67 (2002) 7429.
10. H. M. Meshram, P. N. Reddy, P. Vishnu, K. Sadashiv, J. S. Yadav, Tetrahedron Lett., 47
(2006) 991.
11. J. C. Lee, J. Y. Park, S. Y. Yoon, Y. H. Bae, S. J. Lee, Tetrahedron Lett., 45 (2004) 191.
12. A. Bekaert, O. Provot, O. Rasolojaona, M. Alami, J. D. Brion, Tetrahedron Lett., 46
(2005) 4187.
Chapter 4 Oxybromination
113
13. G. K. S. Prakash, R. Ismail, J. Garcia, C. Panja, G. Rasul, T. Mathew, G. A. Olah,
Tetrahedron Lett., 52 (2011) 1217.
14. A. T. Khan, M. A. Ali, P. Goswami, L. H. Choudhury, J. Org. Chem., 71 (2006) 8961.
15. E.-H. Kim, B.-S. Koo, C.-E. Song, K.-J. Lee, Synth. Commun., 31 (2001) 3627.
16. M. Gaudry, A. Marquet, Tetrahedron, 26 (1970) 5611.
17. R. D. Patil, G. Joshi, S. Adimurthy, B. C. Ranu, Tetrahedron Lett., 50 (2009) 2529.
18. K. Masaru, K. Minoru, K. Yoshimaro, N. Yoshimitsu, Heterocycles, 34 (1992) 747.
19. K. Masaru, K. Minoru, K. Yoshimaro, Tetrahedron, 48 (1992) 67.
20. G. Campiani, V. Nacci, S. Bechelli, S. M. Ciani, A. Garofalo, I. Fiorini, H. Wikstrom, P.
D. Boer, Y. Liao, P. G. Tepper, A. Cagnotto, T. Mennini, J. Med. Chem., 41 (1998) 3763.
21. A. Tsuruoka, Y. Kaku, H. Kakinuma, I. Tsukada, M. Yanagisawa, K. Nara, T. Naito,
Chem. Pharm. Bull., 46 (1998) 623.
22. A. T. Johnson, L. Wang, A. M. Standeven, M. Escobar, R. A. S. Chandraratna, Bioorg.
Med. Chem., 7 (1999) 1321.
23. E. Verner, B. A. Katz, J. R. Spencer, D. Allen, J. Hataye, W. Hruzewicz, H. C. Hui, A.
Kolesnikov, A. Martelli, K. Radika, R. Rai, M. She, W. Shrader, P. A. Sprengeler, S.
Trapp, J. Wang, W. B. Young, R. L. Mackman, J. Med. Chem., 44 (2001) 2753.
24. T. Nittoli, K. Curran, S. Insaf, M. D. Grandi, M. Orlowski, R. Chopra, A. Agarwal,
A. Y. M. Howe, A. Prashad, M. B. Floyd, B. Johnson, A. Sutherland, K. Wheless,
B. Feld, J. O. Connell, T. S. Mansour, J. Bloom, J. Med. Chem., 50 (2007) 2108.
25. R. P. Perera, D. S. Wimalasena, K. Wimalasena, J. Med. Chem., 46 (2003) 2599.
26. G. Wang, Z. Li, C. Ha, K. Ding, Synth. Commun., 38 (2008) 1629.
27. A. Podgorsek, S. Stavber, M. Zupan, J. Iskra, Tetrahedron, 65 (2009) 4429.
Chapter 4 Oxybromination
114
28. A. Latorre, A. Urbano, M. C. Carreno, Chem. Commun., (2009) 6652.
29. P. S. Poon, A. K. Banerjee, J. Chem. Res., (2009) 737.
30. M. Voets, I. Antes, C. Scherer, U. M. Vieira, K. Biemel, S. M. Oberwinkler, R. W.
Hartmann, J. Med. Chem., 49 (2006) 2222.
31. E. Reimann, H. Renz, Arch. Pharm., 326 (1993) 253.
32. T. Sakurai, A. Kageyama, H. Hayashi, H. Inoue, Bull. Chem. Soc. Jpn., 65 (1992) 2948.
33. W. Peter, B. Joachim, Liebigs Ann. Chem., 7 (1992) 669.
34. H. Y. Choi, D. Y. Chi, Org. Lett., 5 (2003) 411.
35. R. V. Hoffman, W. S. Weiner, N. Maslouh, J. Org. Chem., 66 (2001) 5790.
36. K. Kikushima, T. Moriuchi, T. Hirao, Tetrahedron, 66 (2010) 6906.
37. C. H. Jean, T. Eliane, M. Philippe, C. Henri, Phosphorus, Sulfur Silicon Relat.
Elem., 25 (1985) 357.
38. G. Nv, N. Francois, J. Catherine, B. Roland, L. J. Michel, P. Christophe, D. Pierre, T.
Nicolas, W. P. T. B. Paul, N. F. Sylvie, Galapagos, Belgium, PCT Patent No. 029119,
(2010).
39. C. Li, C. X. Jie, L. A. John, Z. Chunlin, Hoffmann-La Roche Ltd, US, US Patent No.
0014958, (2006).
Chapter 4 Oxybromination
115
Section C
Oxybromination of olefins
4.11. State of art
Regioselective functionalization of olefins is an important process in synthetic organic
chemistry. In particular, selective introduction of two functional groups, such as hydroxybromo,
alkoxybromo and dibromo in a highly regio- and stereoselective manner remains important and
challenging task [1]. Bromohydrins are usually prepared by the ring opening of epoxides [2]
using hydrogen bromide or metal bromides. These procedures are generally associated with the
formation of byproducts such as vicinal dibromides, 1,2-diols and these methods also require
prior synthesis of epoxides. Apart from this, there are two general approaches for heterolytic
addition of water (or alcohol) and bromine to an olefinic bond. One, involves the use of
molecular bromine or N-bromoimides [3,6] and the other uses metal bromide or HBr along with
an oxidizing agent [4,5].
Classical bromination involves the use of hazardous elemental bromine, which is a
pollutant and generates hazardous HBr as byproduct. The use of N-bromoimide is a better
alternative for molecular bromine, which does not produce HBr in the bromination of olefins, but
they are expensive and generate organic waste. Another drawbacks of these methods are low
yield and long reaction times.
At present, oxidative bromination continues to be of great interest because it precludes
the use of volatile, hazardous bromine. A number of protocols are available to achieve
bromination of alkenes using Br- instead of Br2. The oxidative bromination requires a metal salt
as bromine source, an oxidizing agent and a catalyst to carry out the transformation. However,
such oxidative brominations involve the use of heavier metals in stoichiometric amounts and
Chapter 4 Oxybromination
116
often resulting in poor yields and selectivity (poor stereo selectivity and unwanted side products).
Most of the reported methods for such transformation rely on modification of molecular
bromine, N-bromoimides or metal salts with an oxidizing agent, whilst the use of other reagents
have been less investigated [8,9]. In spite of the variety of methods available for the preparation
of vic-bromohydrins, bromo ethers and dibromides directly from olefins, many of them often
involve the use of expensive reagents and the formation of mixture of products resulting in low
yields of the desired products. The replacement of such reagents by non-toxic, mild, selective
and easy-to-handle reagents are very desirable and represents an important goal in the context of
clean synthesis.
In this section of the chapter, a very simple, mild and efficient method for direct synthesis
of bromohydrins, bromo ethers and dibromides from olefins using NH4Br as a bromine source
and oxone as an oxidant without catalyst in a highly regio- and stereo selective fashion in short
reaction time has been discussed (Scheme 4.7).
NH4Br, OxoneCH3CN:H2O (1:1)
or CH3CNor ROH
RIRII
RIRII
X
Br
X
Br
RII = H, CH3, CH
2OH, X = OH, Br, OR
RI = Alkyl, Aryl
COR, COOR, Ph
RI
RII
RII
RI
Scheme 4.7. Cobromination and dibromination of olefins
Chapter 4 Oxybromination
117
4.12. General experimental procedure
4.12.1. General information
All chemicals used were reagent grade and used as received without further purification.
1H NMR spectra were recorded at 300, 400 and 500 MHz and
13C NMR spectra 75 MHz in
CDCl3 or DMSO-D6. The chemical shifts () are reported in ppm units relative to TMS as an
internal standard for 1H NMR and CDCl3 for
13C NMR spectra. Coupling constants (J) are
reported in hertz (Hz) and multiplicities are indicated as follows: s (singlet), bs (broad singlet), d
(doublet), dd (doublet of doublet), t (triplet), m (multiplet). Mass spectra were recorded under
impact (EI) conditions at 70 eV. Column chromatography was carried out using silica gel (finer
than 200 mesh)
4.12.2. General procedure for the synthesis of bromohydrins:
To a solution of olefin (2 mmol) in CH3CN/H2O (1:1) (10 mL) were added NH4Br (2.2
mmol) and oxone (2.2 mmol) and the mixture was stirred at room temperature for the time
shown in Table 4.10. After completion (as indicated by TLC), the reaction mixture was filtered
and the solvent evaporated under reduced pressure. The products were purified by column
chromatography (Hexane/EtOAc, 90:10) over silica gel.
4.12.3. General procedure for the synthesis of dibromides:
To a solution of olefin (2 mmol) in CH3CN (10 mL) were added NH4Br (4.4 mmol) and
oxone (2.2 mmol) and the mixture was stirred at reflux temperature for the time shown in Table
4.12. After completion (as indicated by TLC), the reaction mixture was filtered and the solvent
evaporated under reduced pressure. The products were purified by column chromatography
(Hexane/EtOAc, 98:2) over silica gel.
Chapter 4 Oxybromination
118
4.12.4. General procedure for the synthesis of alkoxybromides:
To a solution of olefin (2 mmol) in alcohol (10 ml) were added NH4Br (2.2 mmol) and
oxone (2.2 mmol) and the mixture was stirred at room/reflux temperature for the time shown in
Table 4.14. After completion (as indicated by TLC), the reaction mixture was filtered and the
solvent evaporated under reduced pressure. The products were purified by column
chromatography over silica gel.
4.13. Results and discussion
4.13.1. Hydroxybromination of olefins
4.13.1.1. Optimization of reaction conditions
Initially, we investigated the bromohydroxylation of styrene with NH4Br and oxone in
various solvents such as CH3CN, DCM, CCl4, acetone and in combination with water (Table 4.9,
entries 1–17). The results obtained suggested that a mixture of acetonitrile and water in 1:1 ratio
was the best solvent system for bromohydrin formation (Table 4.9, entry 10).
Chapter 4 Oxybromination
119
Table 4.9. Optimization of the bromohydrins
PhSolvent
OH
Br
Ph +Br
Br
Ph
1a 2a 3a
NH4Br, Oxone
Entry Solvent
Time Yield (%)a
2a 3a
1
2
3
4
5
6
7
8
9
10
11
12
13
14
CH3CN
Acetone
DCM
CHCl3
CCl4
H2O
CH3CN:H2O
(9:1)
CH3CN:H2O
(4:1)
CH3CN:H2O
(3:2)
CH3CN:H2O
(1:1)
CH3CN:H2O
(2:3)
CH3CN:H2O
(1:4)
DCM:H2O
(1:1)
DCM:H2O
(1:1)
24 hb
24 hb
24 hb
24 hb
24 hb
2 minb
10 minb
10 minb
5 minb
2 minb
2 minb
2 minb
3 minb
30 minb
- 60
2 48
- -
9 11
- -
56 29
65 30
84 12
85 10
92 5
83 12
79 16
10 48
10 49
Chapter 4 Oxybromination
120
15
16
17
CHCl3:H2O
(1:1)
CCl4:H2O
(1:1)
Acetone:H2O
(1:1)
3 minb
3 minb
2 minb
8 55
12 40
85 10
a Isolated yields.
b Styrene (2 mmol), NH4Br (2.2 mmol), Oxone (2.2 mmol), Solvent (10 mL), rt.
4.13.1.2. Hydroxybromination of various olefins
Stimulated by these affirmative preliminary results, we decided to examine the NH4Br-
oxone reagent system for hydroxybromination on a number of different activated, inactivated,
and moderately activated aromatic alkenes (Table 4.10, entries 2–7), asymmetric trans-alkenes
(Table 4.10, entries 10–14), symmetric trans/cis alkenes (Table 4.10, entries 15-16), cyclic and
linear alkenes (Table 4.10, entries 17–22) under similar reaction conditions.
Hydroxybromination of all olefins took place quickly and completed in less than or equal to 5
minutes.
Olefin with highly activated arenes, that is, 4-methoxystyrene produced the
corresponding bromohydrin in excellent yield without the formation of ring or dibrominated
products (Table 4.10, entry 2). Olefins with moderately activated arenes (alkyl substituted), i.e.
4-methyl, 4-tert-butyl, and 2,4-dimethylstyrene yielded the corresponding bromohydrins in
moderate to high yields without forming any side-chain and ring brominated products (Table
4.10, entries 3–5). α-Methylstyrene gave the respective bromohydrin in a 97% yield, whereas 4-
chloro-α-methylstyrene afforded the corresponding bromohydrin in an 84% yield, along with a
substantial amount (10%) of dibrominated product (Table 4.10, entries 8 and 9).
Chapter 4 Oxybromination
121
Table 4.10. Synthesis of bromohydrins from various olefinsa
R
RI NH4Br, Oxone
CH3CN : H2O
(1:1)
OH
BrR
RI
Entry Olefin Time (min) Product Yield (%)b
1
2
3
4
5
6
7
8
O
Cl
Br
2
1
2
1
1
2
3
2
OH
Br
OH
BrO
Br
OH
Br
OH
Br
OH
Br
OH
Cl
Br
OH
Br
Br
OH
92 (2a)
90 (2b)
79 (2c)
70 (2d)
66 (2e)
89 (2f)
89 (2g)
97 (2h)
Chapter 4 Oxybromination
122
9
10
11
12
13
14
15
16
17
18
19
Cl CH
2OH
Ph
PhCOCH
3
PhCOOH
PhCOOMe
PhCOPh
PhPh
Ph Ph
2
3
3
3
4
3
5
2
1
3
1
Br
OH
Cl
PhCH
2OH
Br
OH
Ph
Br
OH
COCH3
Ph
Br
OH
COOH
Ph
Br
OH
COOMe
Ph
Br
OH
COPh
Ph
Br
OH
Ph
PhPh
Br
OH
Br
OH
Br
OH
Br
OH
84 (2i)
92c (2j)
77c (2k)
80c (2l)
63c (2m)
62c (2n)
78c (2o)
15c (2o) 51
d (2p)
86 (2q)
85 (2r)
89 (2s)
Chapter 4 Oxybromination
123
20
21
22
23
24
OH
CH3(CH2)9
CH3(CH2)4
O
O
O O
1
2
1
60
60
OH
Br
OH
CH3(CH2)9
Br
OH
CH3(CH2)9Br
OH
CH3(CH2)4Br
OH
CH3(CH2)4
Br
OH
O
O
OH
Br
O O
Br
OH
84 (2t)
47 (2u)
(14) (2uI)
25c (2v)
(36)c (2v
I)
-
-
a
Olefin (2 mmol), NH4Br (2.2 mmol), Oxone (2.2 mmol), CH3CN:H2O (1:1) (10 mL) at room
temperature.
b Isolated yields.
c Only erythro products.
d threo product.
Regio- as well as stereoselective products were formed when asymmetric trans-alkenes
were subjected to bromohydroxylation and selectively corresponding erythro isomers were
obtained. trans-Cinnamyl alcohol provided the corresponding erythro bromohydrin in excellent
yield (Table 4.10, entry 10). When the conjugated ketones, acids and esters with a phenyl group
Chapter 4 Oxybromination
124
at the β-position were subjected to bromohydroxylation under similar reaction conditions,
furnished the corresponding erythro-β-hydroxy-α-bromo products (Table 4.10, entries 11–14).
The role of alkene geometry on the anti stereochemistry of the addition was tested by
conducting reactions with cis and trans-stilbene. Hydroxybromination of cis-stilbene were more
rapid than its trans-isomer and both gave anti addition products. trans-Stilbene produced erythro
hydroxybrominated (Table 4.10, entry 15) product. In case of cis-stilbene, significant amount of
corresponding erythro isomer was also obtained (Table 4.10, entry 16).
Not only aromatic olefins, cyclic and linear olefins also gave the corresponding
hydroxybrominated products in moderate to high yields (Table 4.10, entries 18-22). 1-Methyl-1-
cyclohexene and 3-methyl-3-butene-1-ol exclusively yielded the Markovnikov’s products (Table
4.10, entries 19 and 20), while with monosubstituted linear olefin, a limited anti-Markovnikov
product was also observed. For example, 1-dodecene resulted in the formation of Markovnikov
product (1-bromododecan-2-ol) as well as anti-Markovnikov product (2-bromododecan-1-ol) in
47% and 14% yields, respectively (Table 4.10, entry 21). Mixed regioselectivity is observed with
linear asymmetric trans-alkene, that is, trans-2-octene afforded the erythro-2-bromooctan-3-ol
and erythro-3-bromooctan-2-ol in the ratio of 25:36 (Table 4.10, entry 22).
Bromohydroxylation of electron-deficient double bond in 1,4-naphthoquinone and
coumarin failed to react (Table 4.10, entries 23 and 24). The attempted bromohydroxylation of
cholesterol and cholest-4-ene-3-one resulted in a complex mixture, which contained virtually no
bromohydrin.
Chapter 4 Oxybromination
125
4.13.2. Dibromination of olefins
4.13.2.1. Optimization of reaction conditions
From the investigated results of bromohydroxylation of styrene in different solvents, we
observed that acetonitrile turned out to be the best solvent for the formation of respective
dibrominated product in terms of yield and reaction rates (Table 4.9, entry 1). Thus, we
investigated the dibromination of styrene with NH4Br and oxone in CH3CN and in combination
with H2O at room temperature and reflux temperature (Table 4.11, entries 1-6). One equivalent
of styrene treated with 2.2 equiv of NH4Br and 1.1 equiv of oxone in CH3CN at room
temperature gave the corresponding dibrominated product with an 80% yield in 24 h (Table 4.11,
entry 2). Significant improvement in yield and decrease in reaction time were achieved by
conducting the reaction at reflux temperature and yielded the respective dibrominated product in
a 97% yield within 7 h (Table 4.11, entry 3).
Chapter 4 Oxybromination
126
Table 4.11. Optimization of the dibromides.
PhSolvent
OH
Br
Ph +Br
Br
Ph
1a 2a 3a
NH4Br, Oxone
Entry Solvent
Time Yield (%)a
2a 3a
1
2
3
4
5
6
CH3CN
CH3CN
CH3CN
CH3CN:H2O
(10:0.25)
CH3CN:H2O
(10:0.5)
CH3CN:H2O
(10:1)
5 hb
24 hc
7 hd
19hc
1.3hc
3 minc
- 65
- 80
- 97
13 81
20 73
33 60
a Isolated yields.
b Styrene (2 mmol), NH4Br (2.2 mmol), Oxone (2.2 mmol), Solvent (10 mL), Reflux temperature.
c Styrene (2 mmol), NH4Br (4.4 mmol), Oxone (2.2 mmol), Solvent (10 mL), Room temperature.
d Reflux temperature.
4.13.2.2. Dibromination of various olefins
After optimizing the reaction conditions, we have extended the process to a variety of
olefins, which are summarized in Table 4.12. They were conveniently converted into their
respective dibromides in excellent yields (in exception 4-methoxystyrene and α-methylstyrene
provided a mixture of unidentified products (Table 4.12, entries 2, 8 and 9)).
Dibromination of asymmetric trans-alkenes selectively formed the corresponding erythro
isomers (Table 4.12, entries 10–14). The role of alkene geometry on the anti stereochemistry of
the addition was tested by conducting reactions with cis and trans-stilbene. Dibromination of cis-
Chapter 4 Oxybromination
127
Table 4.12. Synthesis of dibromides from various olefinsa
R
RI NH4Br, Oxone
CH3CN
Br
BrR
RI
Entry Olefin Time (h) Product Yield (%)b
1
2
3
4
5
6
7
8
O
Cl
Br
7
-
5
4
6
13
13
10
Br
Br
Br
BrO
Br
Br
Br
Br
Br
Br
Br
Br
Cl
Br
Br
Br
Br
Br
97 (3a)
-
95 (3c)
92 (3d)
90 (3e)
96 (3f)
90 (3g)
- (3h)
Chapter 4 Oxybromination
128
9
10
11
12
13
14
15
16
17
18
19
Cl CH
2OH
Ph
PhCOCH
3
PhCOOH
PhCOOMe
PhCOPh
PhPh
Ph Ph
10
12
15
13
12
13
20c
16c
8.3
23c
20c
Br
Br
Cl
PhCH
2OH
Br
Br
Ph
Br
Br
COCH3
Ph
Br
Br
COOH
Ph
Br
Br
COOMe
Ph
Br
Br
COPh
Ph
Br
Br
Ph
PhPh
Br
Br
Br
Br
Br
Br
Br
Br
- (3i)
98d (3j)
90d (3k)
96d (3l)
97d
(3m)
97d (3n)
80d
(3o)
95e (3p)
90 (3q)
96 (3r)
93 (3s)
Chapter 4 Oxybromination
129
20
21
22
23
24
OH
CH3(CH2)9
CH3(CH2)4
O
O
O O
4
9
5
5
10
OH
Br
Br
CH3(CH2)9Br
Br
CH3(CH2)4Br
Br
O
O
Br
O O
Br
Br
89 (3t)
97 (3u)
96d (3v)
97 (3w)
23 (3x)
a Olefin (2 mmol), NH4Br (4.4 mmol), Oxone (2.2 mmol), CH3CN (10 mL) at reflux temperature.
b Isolated yields.
c Room temperature.
d Only erythro products.
e threo product.
stilbene were more rapid than its trans-isomer and both gave anti addition products. trans-
Stilbene produced meso dibrominated product (Table 4.12, entry 15), whereas cis-stilbene
afforded the corresponding threo dibrominated product (Table 4.12, entry 16). Cyclic and linear
alkenes furnished the corresponding dibrominated products in excellent yields (Table 4.12,
entries 18-22). In case of 1,4-naphthoquinone, instead of the expected dibrominated product, 2-
bromo-1,4-naphthoquinone was obtained in excellent yield (Table 4.12, entry 23).
Chapter 4 Oxybromination
130
4.13.3. Alkoxybromination of olefins
Initially methanolic solution of 1 equivalent of styrene was treated with 1.1 equivalents
of NH4Br and 1.1 equivalents of oxone at room temperature. After 50 minutes, complete
disappearance of styrene was observed (indicated by TLC) and 2-bromo-1-methoxystyrene was
formed in excellent yield (Table 4.13, entry 1). Here methanol served as the reaction medium
as well as the nucleophile source. Encouraged by this result, we decided to test the scope of
other alcohols in the alkoxybromination of styrene at room temperature and 80C and the data
obtained were presented in Table 4.13. Among the different alcohols, primary alcohols (such as
EtOH, n-PrOH and n-BuOH) gave the corresponding alkoxybromo products in good yields,
while secondary (2-PrOH, 2-BuOH) and tertiary alcohols (t-BuOH) provided poor yields due to
steric hindrance.
A number of different olefins were used as reactants in the methoxy and
ethoxybromination with NH4Br/oxone reagent system and results are summarized in Table 4.14.
Activated, inactivated and moderately activated aromatic olefins furnished the respective 2-
bromo-1-methoxy and 2-bromo-1-ethoxy products in high yields with-out forming any side-
chain and ring brominated products (Table 4.14, entries 2-7).
Selectively erythro isomer was formed when asymmetric trans-alkenes were subjected
to alkoxybromination (Table 4.14, entries 10-14). In ethanol a distinct difference of products
were observed between room and reflux temperature with 4-phenyl-3-butene-2-one (5). At
reflux temperature, the corresponding -brominated product i.e. 1-bromo-4-phenyl-3-butene-2-
one (6) was obtained in 50% yield. On the contrary, reaction at room temperature resulted in
the formation of the respective double bond addition products i.e. ethoxybrominated (mixture
of erythro and threo (65:35)) and dibrominated product (Scheme 4.8).
Chapter 4 Oxybromination
131
Table 4.13. Alkoxybromination of styrene using various alcoholsa
PhNH4Br, Oxone
ROH
OR
Br
Ph+
Br
Br
Ph
1a 4 3a
Entry ROH Time Yield (%)b
4 3a
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
MeOH
EtOH
,,
n-PrOH
,,
i-PrOH
,,
n-BuOH
,,
2-BuOH
,,
i-BuOH
,,
t-BuOH
,,
50 minc
24 hc
2.45 hd
24 hc
11 hd
24 hc
10 hd
24 hc
10 hd
24 hc
12 hd
24 hc
12.3 hd
42 hc
10.3 hd
85 <5
64 14
84 <5
55 22
70 9
30 41
35 12
50 15
61 <5
6 12
8 <5
25 19
34 10
7 30
22 55
aStyrene (2 mmol), NH4Br (2.2 mmol), Oxone (2.2 mmol), ROH (10 mL).
bIsolated yields.
cAt room temperature.
dAt 80˚C.
Chapter 4 Oxybromination
132
Table 4.14. Methoxy and Ethoxybromination of various aromatic olefins
Entry Olefin Product R Time Yield (%)a
1
2
3
4
5
6
7
8
9
10
O
Cl
Br
Cl
CH
2OH
Ph
OR
Br
OR
BrO
Br
OR
Br
OR
Br
OR
Br
OR
Cl
Br
OR
Br
Br
OR
Br
OR
Cl
PhCH
2OH
Br
OR
Me
Et
Me
Et
Me
Et
Me
Et
Me
Et
Me
Et
Me
Et
Me
Et
Me
Et
Me
Et
50 minb
2.45 hc
40 minb
2 hc
15 minb
45 minc
6 minb
1.15 hc
15 minb
2.30 hc
30 minb
3 hc
1 hb
3 hc
13 minb
2.15 hc
15 minb
2 hc
40 minb
3.30 hc
85 (4a)
84 (4A)
90 (4b)
92 (4B)
93 (4c)
84 (4C)
80 (4d)
75(4D)
76 (4e)
80 (4E)
91 (4f)
85 (4F)
84 (4g)
85 (4G)
92 (4h)
83 (4H)
88 (4i)
72 (4I)
84e (4j)
89e (4J)
Chapter 4 Oxybromination
133
11
12
13
14
15
16
17
18
19
20
21
PhCOCH
3
PhCOOH
PhCOOMe
PhCOPh
PhPh
Ph Ph
OH
CH3(CH2)9
Ph
Br
OR
COCH3
Ph
Br
OR
COOH
Ph
Br
OR
COOMe
Ph
Br
OR
COPh
Ph
Br
OR
Ph
PhPh
Br
OR
Br
OR
Br
OR
Br
OR
OH
Br
OR
CH3(CH2)9Br
OR
CH3(CH2)9
Br
OR
Me
Me
Et
Me
Et
Me
Et
Me
Et
Me
Et
Me
Et
Me
Et
Me
Et
Me
Et
Me
Et
Me
Et
2.15 hb
2.30 hb
24 hd
3 hb
24 hd
1 hb
3.3 hc
1.3 hb
3.3 hc
1 hb
1.3 hc
15 minb
4 hc
5 minb
24 hd
10 minb
24 hd
30 minb
2.3 hc
45 minb
4 hc
76e (4k)
76e (4l)
31e (4L)
71e (4m)
20e (4M)
70e (4n)
75g (4N)
80e (4o)
76e (4O)
73f (4p)
40h
(4P)
76 (4q)
81 (4Q)
64 (4r)
34(4R)
71 (4s)
66(4S)
75 (4t)
63 (4T)
60 (4u)
54 (4U)
5 (4uI)
5 (4UI)
Chapter 4 Oxybromination
134
22
23
24
CH3(CH2)4
O
O
O O
CH3(CH2)4
Br
OR
CH3(CH2)4
Br
OR
O
O
Br
OR
O O
Br
OR
Me
Et
Me
Et
Me
Et
Me
Et
45 minb
4 hc
24 hb
5 hc
24 hb
10 hc
24 (4v)
18 (4V)
39 (4vI)
33 (4VI)
-
-
-
-
aIsolated yields.
bOlefin (2 mmol), NH4Br (2.2 mmol), Oxone (2.2 mmol), MeOH (10 mL) at room temperature.
cOlefin (2 mmol), NH4Br (2.2 mmol), Oxone (2.2 mmol), EtOH (10 mL) at reflux temperature.
dAt room temperature.
eerythro products.
fthreo products.
gMolar ratio of erythro and threo 62:38, determined by
1H NMR.
hMolar ratio of threo and erythro 33:67, determined by
1H NMR.
In case of symmetric olefins (Table 4.14, entries 15 and 16), trans-stilbene produced the
corresponding erythro-methoxybromo product (4o), whereas cis-stilbene gave the respective
threo-methoxybromo product (4p) in methanol. In ethanol trans-stilbene yielded selectively
erythro-ethoxybromo product (4O), whilst cis-stilbene furnished mixture of threo and erythro
isomers.
Cyclic and linear olefins also provided good results with this reagent system (Table 4.14,
entries 18-22). Exclusively Markovnikov’s product was formed with 1-methyl-1-cyclohexane
and 3-methyl-3-butene-1-ol (Table 4.14, entries 19-20). In case of linear olefins regioselectivity
was not observed, for example 1-dodecene gave the corresponding Markovnikov’s product
(4u/4U) and anti-Markovnikov product (4uI/4U
I), while mixed regioselectivity was observed for
Chapter 4 Oxybromination
135
trans-2-octene (Table 4.14, entries 21-22). 1,4-Naphthoquinone furnished the 2-bromo-1,4-
naphthoquinone instead of the expected alkoxybrominated product in excellent yield (Table 4.14,
entry 23). The stereochemistry of the products is confirmed by comparing the 1H NMR coupling
constant data of protons attached to the carbons bearing -OR and -Br groups of the
alkoxybromides with previously reported data.
O
Ph
NH4Br, Oxone
EtOHO
Ph
Br
OEt O
Ph
Br
Br
Reflux5 h
rt
24 h
5
+
O
PhBr
50% 6
7 3k
59% 15%
Scheme 4.8. Bromnination of 4-phenyl-3-butene-2-one in ethanol
4.13.4. Mechanism
The plausible reaction mechanism for cobromination and dibromination of olefins is
shown in Scheme 4.9. It is assumed that oxidation of bromide ion by peroxymonosulfate ion
could give the hypobromite ion, which further undergoes electrophilic addition onto the olefin to
give cyclic bromonium ion intermediate. The cyclic intermediate is attacked by the nucleophile
of corresponding solvent or bromide ion of ammonium bromide via the SN2
path way to yield
anti vicinal hydroxybromo / alkoxybromo / dibromo substituted product. In all aromatic olefins,
the incoming nucleophile entered at the benzylic position of cyclic intermediate exclusively. The
stereochemistry of the products are confirmed by comparing the 1H NMR coupling constant data
of protons attached to the carbons bearing –OH/-Br/-OR and –Br groups of the bromohydrins /
dibromides / alkoxybromides with previously reported data [5-12].
Chapter 4 Oxybromination
136
RI
RIIHO- Br+
Br
RIRII
+-OH
RO- H+
OR
Br
RII
RI + H2O
Br
Br
RIRII
NH4+ Br-
+NH4OH
R = H / Alkyl
HSO5- + Br- HOBr + SO4
-2
Scheme 4.9. The plausible reaction mechanism
4.14. Spectral data
2-Bromo-1-phenylethanol (2a) [5e]
1H NMR (300 MHz, CDCl3): 2.61 (bs, 1 H), 3.45-3.63 (m, 2 H), 4.87 (dd, 1 H, J = 3.02, 9.06
Hz), 7.25-7.36 (m, 5 H).
13C NMR (75 MHz, CDCl3): 40, 73.8, 125.9, 128.4, 128.6, 140.2.
MS (EI): m/z (%) = 202 [M + 2]+ (2), 200 [M
+] (2), 121 (1), 107 (100), 91 (7), 79 (45), 65 (4), 51
(21).
2-Bromo-1-(4-methoxyphenyl)ethanol (2b) [5d]
1H NMR (300 MHz, CDCl3): 2.50 (bs, 1 H), 3.43-3.59 (m, 2 H), 3.79 (s, 3 H), 4.79-4.86 (m, 1
H), 6.85 (d, 2 H, J = 8.3 Hz), 7.26 (d, 2 H, J = 8.3 Hz).
2-Bromo-1-(4-methylphenyl)ethanol (2c) [5d]
1H NMR (400 MHz, CDCl3): 2.35 (s, 3 H), 2.54 (bs, 1 H), 3.42-3.60 (m, 2 H), 4.82 (dd, 1 H, J
= 3.75, 9.02 Hz), 7.12 (d, 2 H, J = 8.26 Hz), 7.22 (d, 2 H, J = 8.26 Hz).
13C NMR (75 MHz, CDCl3): 21.1, 40.1, 73.6, 125.8, 129.3, 137.3, 138.2.
Chapter 4 Oxybromination
137
MS (EI): m/z (%) = 216 [M + 2]+ (4), 214 [M
+] (4), 121 (100), 105 (15), 91 (70), 77 (51), 65
(26), 51 (13).
2-Bromo-1-(2,4-dimethylphenyl)ethanol (2d) [11]
1H NMR (300 MHz, CDCl3): 2.30 (s, 6 H), 2.51 (bs, 1 H), 3.38-3.55 (m, 2 H), 5.04 (dd, 1 H, J
= 3.02, 9.06 Hz), 6.92 (s, 1 H), 7.00 (d, 1 H, J = 7.55 Hz), 7.35 (d, 1 H, J = 8.3 Hz).
MS (EI): m/z (%) = 230 [M + 2]+ (2), 228 [M
+] (2), 135 (100), 119 (15), 107 (60), 91 (63), 77
(25), 65 (13), 51 (14).
2-Bromo-1-(4-chlorophenyl)ethanol (2f) [5e]
1H NMR (300 MHz, CDCl3): 2.66 (bs, 1 H), 3.40-3.60 (m, 2 H), 4.85 (dd, 1 H, J = 3.21, 8.87
Hz), 7.25-7.35 (m, 4 H).
13C NMR (75 MHz, CDCl3): 39.9, 72.8, 127.3, 129, 134.2, 138.8.
2-Bromo-1-(4-bromophenyl)ethanol (2g) [5e]
1H NMR (500 MHz, CDCl3): 2.66 (bs, 1 H), 3.42-3.62 (m, 2 H), 4.85 (dd, 1 H, J = 3.12, 9.37
Hz), 7.25 (d, 2 H, J = 8.32 Hz), 7.49 (d, 2 H, J = 8.32 Hz)
1-Bromo-2-phenylpropan-2-ol (2h) [5d]
1H NMR (300 MHz, CDCl3): 1.65 (s, 3 H), 2.47 (bs, 1 H), 3.66 (d, 1 H, J = 10.38 Hz), 3.72 (d,
1 H, J = 10.38 Hz), 7.24 (m, 1 H), 7.33 (m, 2 H), 7.42 (d, 2 H, J = 7.36 Hz).
13C NMR (75 MHz, CDCl3): 28, 46.2, 73.1, 124.7, 127.5, 128.4, 144.1.
MS (EI): m/z (%) = 216 [M + 2]+ (0.5), 214 [M
+] (0.5), 121 (100), 105 (22), 91 (39), 77 (44), 51
(43).
erythro-2-Bromo-3-hydroxy–3-phenylpropan-1-ol (2j) [5d]
1H NMR (300 MHz, CDCl3): 3.82 (dd, 1 H, J = 5.28, 12.84 Hz), 3.96 (dd, 1 H, J = 5.28, 12.84
Hz), 4.20 (ddd, 1 H, J = 4.53, 5.2, 6.04 Hz), 4.95 (d, 1 H, J = 6.04 Hz), 7.22-7.38 (m, 5 H).
Chapter 4 Oxybromination
138
13C NMR (75 MHz, CDCl3): 59.3, 64.1, 76.7, 126.5, 128.4, 128.5, 140.2.
erythro-3-Bromo-4-hydroxy–4-phenylbutan-2-one (2k) [1d]
1H NMR (300 MHz, CDCl3): 2.37 (s, 3 H), 3.34 (bs, 1 H), 4.30 (d, 1 H, J = 8.68 Hz), 4.98 (d,
1 H, J = 8.68 Hz), 7.24-7.38 (m, 5 H).
erythro-2-Bromo-3-hydroxy-3-phenylpropanoic aicd (2l) [7]
1H NMR (300 MHz, DMSO-D6): 4.16 (d, 1 H, J = 9.44 Hz), 4.88 (d, 1 H, J = 9.44 Hz), 7.23-
7.46 (m, 5 H).
erythro-Methyl-2-bromo-3-hydroxy-3-phenylpropionate (2m) [10a]
1H NMR (300 MHz, CDCl3): 3.38 (bs, 1 H), 3.78 (s, 3 H), 4.27 (d, 1 H, J = 8.49 Hz), 4.99 (d, 1
H, J = 8.49 Hz), 7.24-7.38 (m, 5 H).
13C NMR (75 MHz, CDCl3): 47.3, 53.1, 75.1, 126.9, 128.5, 128.7, 138.9, 169.8.
MS (EI): m/z (%) = 260 [M + 2]+ (0.5), 258 [M
+] (0.5), 107 (100), 91 (28), 79 (70), 51 (28).
erythro-2-Bromo-3-hydroxy-1,3-diphenylpropan-1-one (2n) [7]
1H NMR (300 MHz, CDCl3): 3.36 (bs, 1 H), 5.12 (d, 1 H, J = 8.3 Hz), 5.28 (d, 1 H, J = 8.3
Hz), 7.3-7.5 (m, 7 H), 7.58 (t, 1 H, J = 7.36, 14.73 Hz), 8.01 (d, 2 H, J = 7.36 Hz).
13C NMR (75 MHz, CDCl3): 47.8, 74.7, 127.2, 128.2, 128.4, 128.6, 128.8, 128.9, 134.1, 134.5,
139.3, 194.5.
erythro-2-Bromo-1,2-diphenylethanol (2o) [10f]
1H NMR (300 MHz, CDCl3): 2.30 (bs, 1 H), 5.03 (d, 1 H, J = 6.7 Hz), 5.15 (d, 1 H, J = 6.7
Hz), 7.2-7.35 (m, 10 H).
13C NMR (75 MHz, CDCl3): 58.9, 78.1, 127, 128.2, 128.3, 128.4, 128.7, 128.9, 137.6, 139.7.
threo-2-Bromo-1,2-diphenylethanol (2p) [10f]
Chapter 4 Oxybromination
139
1H NMR (300 MHz, CDCl3): 2.94 (bs, 1 H), 4.97 (d, 1 H, J = 9.06 Hz), 5.06 (d, 1 H, J = 9.06
Hz), 7.03-7.20 (m, 10 H).
13C NMR (75 MHz, CDCl3): 64.3, 78.3, 126.8, 128.2, 128.3, 128.4, 128.5, 138.2, 138.6.
trans-2-Bromo-1-hydroxyindane (2q) [5d]
1H NMR (500 MHz, CDCl3): 3.20 (dd, 1 H, J = 7.95, 15.91 Hz), 3.55 (dd, 1 H, J = 5.96, 15.91
Hz), 4.20-4.26 (m, 1 H), 5.27 (d, 1 H, J = 5.59 Hz), 7.16-7.42 (m, 5 H).
13C NMR (75 MHz, CDCl3): 40.4, 54.5, 83.3, 124, 124.5, 127.6, 129, 139.7, 141.6
trans-2-Bromocyclohexan-1-ol (2r) [5d]
1H NMR (300 MHz, CDCl3): 1.20-1.46 (m, 3 H), 1.64-1.92 (m, 3 H), 2.14 (m, 1 H), 2.35 (m, 1
H), 2.60 (bs, 1 H), 3.50-3.62 (m, 1 H), 3.80-3.92 (m, 1 H).
trans-2-Bromo-1-methylcyclohexan-1-ol (2s) [10b]
1H NMR (300 MHz, CDCl3): 1.33 (s, 3 H), 1.35-2.29 (m, 9 H), 4.10 (dd, 1 H, J = 4.15, 11.14
Hz).
1-Bromododecan-2-ol (2u) [10c]
1H NMR (300 MHz, CDCl3): 0.88 (t, 3 H, J = 6.79 Hz), 1.22-1.57 (m, 18 H), 2.05 (bs, 1 H),
3.3-3.38 (m, 1 H), 3.50 (dd, 1 H, J = 3.77, 10.57 Hz), 3.68-3.79 (m, 1 H).
13C NMR (75 MHz, CDCl3): 14.1, 22.6, 25.6, 29.3, 29.5, 29.6, 29.6, 31.9, 35.1, 40.7, 71.1.
2-Bromododecan-1-ol (2uI) [10c]
1H NMR (300 MHz, CDCl3): 0.88 (t, 3 H, J = 6.98 Hz), 1.22-1.60 (m, 16 H), 1.78-1.88 (m, 2
H), 1.97 (bs, 1 H), 3.65-3.82 (m, 2 H), 4.04-4.14 (m, 1 H).
13C NMR (75 MHz, CDCl3): 14.1, 22.7, 27.4, 29, 29.3, 29.4, 29.5, 29.6, 31.9, 34.8, 60.2, 67.3.
erythro-2-Bromooctan-3-ol (2v) [5d]
Chapter 4 Oxybromination
140
1H NMR (300 MHz, CDCl3): 0.91 (t, 3 H, J = 6.79 Hz), 1.22-1.60 (m, 8 H), 1.64 (d, 3 H, J =
6.79 Hz), 1.96 (bs, 1 H), 3.64-3.72 (m, 1 H), 4.17-4.26 (m, 1 H).
erythro-3-Bromooctan-2-ol (2vI) [5d]
1H NMR (300 MHz, CDCl3): 0.91 (t, 3 H, J = 6.79 Hz), 1.24 (d, 3 H, J = 6.04 Hz), 1.27-1.82
(m, 8 H), 1.99 (bs, 1 H), 3.73-3.82 (m, 1 H), 4.08-4.16 (m, 1 H).
13C NMR (75 MHz, CDCl3): 14, 19, 22.4, 27.5, 31.1, 33.9, 66.2, 70.3.
1,2-Dibromo-1-phenylethane (3a) [5e]
1H NMR (300 MHz, CDCl3): 3.98-4.08 (m, 2 H), 5.06-5.12 (dd, 1 H, J = 5.28, 5.47 Hz), 7.28-
7.40 (m, 5 H).
1,2-Dibromo-1-(4-methylphenyl)ethane (3c) [5b]
1H NMR (300 MHz, CDCl3): 2.36 (s, 3 H), 4.01-4.06 (m, 2 H), 5.08 (dd, 1 H, J = 5.28, 10.57
Hz), 7.15 (d, 2 H, J = 7.55 Hz), 7.26 (d, 2 H, J = 7.55 Hz)
1,2-Dibromo-1-(4-chlorophenyl)ethane (3f) [5b]
1H NMR (300 MHz, CDCl3): 3.89-4.08 (m, 2 H), 5.06 (dd, 1 H, J = 5.09, 11.33 Hz), 7.28-7.40
(m, 4 H).
13C NMR (75 MHz, CDCl3): 34.6, 49.5, 128.9, 129.1, 134.9, 137.1.
erythro-2,3-Dibromo-3-phenylpropan-1-ol (3j) [6]
1H NMR (300 MHz, CDCl3): 4.16-4.36 (m, 2 H), 4.61-4.70 (m, 1 H), 5.22 (d, 1 H, J = 11.14
Hz), 7.25-7.40 (m, 5 H).
MS (EI): m/z (%) = 296 [M + 4]+ (0.5), 294 [M + 2]
+ (1), 292 [M
+] (0.5), 91 (100), 77 (81), 51
(62).
erythro-3,4-Dibromo-4-phenylbutan-2-one (3k) [5c]
Chapter 4 Oxybromination
141
1H NMR (300 MHz, CDCl3): 2.45 (s, 3 H), 4.86 (d, 1 H, J = 11.52 Hz), 5.26 (d, 1 H, J = 11.52
Hz), 7.28-7.45 (m, 5 H).
erythro-2,3-Dibromo-3-phenylpropanoic aicd (3l) [10d]
1H NMR (300 MHz, DMSO-D6): 4.84 (d, 1 H, J = 11.7 Hz), 5.32 (d, 1 H, J = 11.7 Hz), 7.30-
7.47 (m, 5 H).
erythro-Methyl-2,3-dibromo-3-phenylpropionate (3m) [5e]
1H NMR (500 MHz, CDCl3): 3.89 (s, 3 H), 4.77 (d, 1 H, J = 11.7 Hz), 5.29 (d, 1 H, J = 11.7
Hz), 7.25-7.40 (m, 2 H).
13C NMR (75 MHz, CDCl3): 46.7, 50.8, 53.4, 128, 128.9, 129.4, 137.5, 168.3.
MS (EI): m/z (%) = 324 [M + 4]+ (0.5), 322 [M + 2]
+ (1), 320 [M
+] (0.5), 103 (100), 91 (3), 77
(73), 51 (76).
erythro-2,3-Dibromo-1,3-diphenylpropan-1-one (3n) [5c]
1H NMR (300 MHz, CDCl3): 5.54 (d, 1 H, J = 11.33 Hz), 5.77 (d, 1 H, J = 11.33 Hz), 7.34-
7.70 (m, 8 H), 8.08 (d, 2 H, J = 7.55 Hz).
13C NMR (75 MHz, CDCl3): 46.8, 49.8, 128.3, 128.8, 128.9, 129, 129.3, 134.2, 134.4, 138.2,
191.2
meso-1,2-Dibromo-1,2-diphenylethane (3o) [5a]
1H NMR (300 MHz, CDCl3): 5.40 (s, 2 H), 7.30-7.42 (m, 6 H), 7.45-7.50 (m, 4 H)
threo-1,2-Dibromo-1,2-diphenylethane (3p) [5a]
1H NMR (300 MHz, CDCl3): 5.42 (s, 2 H), 7.14 (s, 10 H).
trans-1,2-Dibromoindane (3q) [5e]
1H NMR (300 MHz, CDCl3): 3.24 (d, 1 H, J = 17.64 Hz), 3.80 (dd, 1 H, J = 5.88, 17.64 Hz),
4.83 (d, 1 H, J = 4.9 Hz), 5.58 (s, 1 H), 7.20-7.33 (m, 4 H).
Chapter 4 Oxybromination
142
trans-1,2-Dibromocyclohexane (3r) [5d]
1H NMR (300 MHz, CDCl3): 1.48-1.61 (m, 2 H), 1.75-1.96 (m, 4 H), 2.39-2.53 (m, 2 H), 4.48
(s, 2 H).
1,2-Dibromododecane (3u) [12]
1H NMR (300 MHz, CDCl3): 0.88 (t, 3 H, J = 6.98 Hz), 1.24-1.65 (m, 16 H), 1.69-1.86 (m, 1
H), 2.09-2.21 (m, 1 H), 3.59 (t, 1 H, J = 10.19 Hz), 3.84 (dd, 1 H, J = 4.34, 10.19 Hz), 4.08-4.19
(m, 1 H).
13C NMR (75 MHz, CDCl3): 14.1, 22.7, 26.7, 28.8, 29.3, 29.4, 29.5 29.6, 31.9, 36, 36.3, 53.1.
erythro-2,3-Dibromooctane (3v) [4a]
1H NMR (300 MHz, CDCl3): 0.92 (t, 3 H, J = 6.79 Hz), 1.24-1.70 (m, 6 H), 1.82-1.96 (m, 4
H), 2.08-2.20 (m, 1 H), 4.02-4.10 (m, 1 H), 4.12-4.23 (m, 1 H).
13C NMR (75 MHz, CDCl3): 14, 22.4, 25, 26.6, 31, 37.1, 52.4, 61.8.
2-Bromo-1,4-naphthoquinone (3w) [10e]
1H NMR (300 MHz, CDCl3): 7.51 (s, 1 H), 7.72-7.82 (m, 2 H), 8.05-8.12 (m, 1 H), 8.15-8.20
(m, 1 H).
2-Bromo-1-methoxy-1-phenylethane (4a) [5e]
1H NMR (300 MHz, CDCl3): 3.28 (s, 3 H), 3.38 (dd, 1 H, J = 6.04, 10.5 Hz), 3.48 (dd, 1 H, J =
2.26, 10.57 Hz), 4.32 (dd, 1 H, J = 4.5, 4.53 Hz), 7.28-7.40 (m, 5 H).
13C NMR (75 MHz, CDCl3): 36.8, 57.8, 83.3, 126.6, 128.5, 128.7, 138.9.
MS (EI, 70 eV): m/z (%) = 216 [M + 2]+ (6), 214 [M
+] (6), 121 (100), 91 (15), 77 (30), 51 (7).
2-Bromo-1-methoxy-1-(4-methylphenyl)ethane (4c) [5e]
1H NMR (300 MHz, CDCl3): 2.36 (s, 3 H), 3.27 (s, 3 H), 3.36-3.52 (m, 2 H), 4.28 (dd, 1 H, J =
4.53, 8.3 Hz), 7.10-7.20 (m, 4 H).
Chapter 4 Oxybromination
143
13C NMR (75 MHz, CDCl3): 21.2, 36.4, 57.1, 83.3, 126.7, 129.3, 135.9, 138.3.
MS (EI, 70 eV): m/z (%) = 230 [M + 2]+ (18), 228 [M
+] (17), 135 (100), 117 (30), 91 (45), 77
(5), 65 (8), 51 (10).
2-Bromo-1-methoxy-1-(2,4-dimethylphenyl)ethane (4d)
1H NMR (300 MHz, CDCl3): δ 2.30 (s, 3 H), 2.32 (s, 3 H), 3.26 (s, 3 H), 3.30-3.45 (m, 2 H),
4.55 (dd, 1 H, J = 3.77, 8.30 Hz), 6.93 (s, 1 H), 7.00 (d, 1 H, J = 8.30 Hz), 7.21 (d, 1 H, J = 8.30
Hz).
13C NMR (75 MHz, CDCl3): δ 19.0, 21.0, 35.5, 57.1, 80.1, 125.9, 127.1, 131.5, 133.9, 135.6,
137.8.
Anal. Calcd for C11H15BrO: C, 54.33; H, 6.21. Found: C, 54.21; H, 6.28.
2-Bromo-1-methoxy-1-(4-t-butylphenyl)ethane (4e) [5f]
1H NMR (300 MHz, CDCl3): 1.32 (s, 9 H), 3.29 (s, 3 H), 3.34-3.52 (m, 2 H), 4.30 (dd, 1 H, J
= 4.15, 8.3 Hz), 7.20 (d, 2 H, J = 8.12 Hz), 7.34 (d, 2 H, J = 8.3 Hz).
13C NMR (75 MHz, CDCl3): 31.3, 34.6, 36.4, 57.2, 83.2, 125.5, 126.4, 135.9, 151.4.
MS (EI, 70 eV): m/z (%) = 272 [M + 2]+ (0.5), 270 [M
+] (0.5), 177 (100), 162 (55), 147 (26), 117
(11), 91 (15), 77 (7), 57 (10).
2-Bromo-1-methoxy-1-(4-chlorophenyl)ethane (4f) [5e]
1H NMR (300 MHz, CDCl3): 3.29 (s, 3 H), 3.32-3.52 (m, 2 H), 4.30 (dd, 1 H, J = 4.91, 7.55
Hz), 7.25 (d, 2 H, J = 8.49 Hz), 7.34 (d, 2 H, J = 8.49 Hz).
13C NMR (75 MHz, CDCl3): 35.9, 57.3, 82.6, 128.1, 128.8, 134.3, 137.5.
2-Bromo-1-methoxy-1-(4-bromophenyl)ethane (4g) [5e]
1H NMR (300 MHz, CDCl3): 3.29 (s, 3 H), 3.32-3.50 (m, 2 H), 4.29 (dd, 1 H, J = 4.53, 7.55
Hz), 7.20 (d, 2 H, J = 9 Hz), 7.50 (d, 2 H, J = 9 Hz)
Chapter 4 Oxybromination
144
1-Bromo-2-methoxy-2-phenylpropane (4h) [5e]
1H NMR (300 MHz, CDCl3): 1.69 (s, 3 H), 3.12 (s, 3 H), 3.45 (d, 1 H, J = 10.38 Hz), 3.57 (d, 1
H, J = 10.38 Hz), 7.23-7.41 (m, 5 H).
13C NMR (75 MHz, CDCl3): 21.8, 43.1, 51, 77.8, 126.4, 127.8, 128.4, 141.7.
1-Bromo-2-methoxy-2-(4-chlorophenyl)propane (4i)
1H NMR (300 MHz, CDCl3): δ 1.67 (s, 3 H), 3.12 (s, 3 H), 3.4-3.55 (m, 2 H), 7.28-7.32 (m, 4
H).
13C NMR (75 MHz, CDCl3): δ 21.6, 42.5, 51, 77.6, 127.9, 128.6, 133.7, 140.3.
Anal. Calcd for C10H12BrClO: C, 45.57; H, 4.58. Found: C, 45.61; H, 4.78.
erythro-2-Bromo-3-methoxy–3-phenylpropan-1-ol (4j) [5e]
1H NMR (300 MHz, CDCl3): 2.65 (bs, 1 H), 3.22 (s, 3 H), 3.60-3.90 (m, 2 H), 4.18-4.25 (m, 1
H), 4.50 (d, 1 H, J = 7.36 Hz), 7.24-7.42 (m, 5 H).
13C NMR (75 MHz, CDCl3): 57.5, 57.8, 64.6, 86, 127.5, 128.4, 128.5, 138.
MS (EI, 70 eV): m/z (%) = 246 [M + 2]+ (0.5), 244 [M
+] (0.5), 121 (100), 105 (41), 91 (70), 77
(87), 51 (38).
erythro-3-Bromo-4-methoxy-4-phenylbutan-2-one (4k) [17]
1H NMR (300 MHz, CDCl3): 2.36 (s, 3 H), 3.19 (s, 3 H), 4.18 (d, 1 H, J = 9.44 Hz), 4.50 (d, 1
H, J = 9.44 Hz), 7.24-7.42 (m, 5 H).
erythro-2-Bromo-3-methoxy-3-phenylpropanoic acid (4l) [5f]
1H NMR (300 MHz, DMSO-D6): 3.28 (s, 3 H), 4.18 (d, 1 H, J = 9.82 Hz), 4.52 (d, 1 H, J =
9.82 Hz), 7.32-7.40 (m, 5 H).
erythro-Methyl-2-bromo-3-methoxy-3-phenylpropionate (4m) [10a]
Chapter 4 Oxybromination
145
1H NMR (300 MHz, CDCl3): 3.22 (s, 3 H), 3.84 (s, 3 H), 4.14 (d, 1 H, J = 9.82 Hz), 4.50 (d, 1
H, J = 9.82 Hz), 7.30-7.52 (m, 5 H).
13C NMR (75 MHz, CDCl3): 47, 53, 57.5, 84, 128, 128.3, 128.9, 136.7, 169.4.
erythro-2-Bromo-3-methoxy-1,3-diphenylpropan-1-one (4n) [5f]
1H NMR (400 MHz, CDCl3): 3.18 (s, 3 H), 4.80 (d, 1 H, J = 9.76 Hz), 5.02 (d, 1 H, J = 9.76
Hz), 7.30-7.50 (m, 7 H), 7.56 (t, 1 H, J = 7.32, 14.64 Hz), 8.01 (d, 2 H, J = 7.32 Hz).
13C NMR (75 MHz, CDCl3): 47.2, 57.6, 83.3, 128.2, 128.3, 128.7, 133.7, 135.2, 137.8, 193.1.
erythro-1-Bromo-2-methoxy-1,2-diphenylethane (4o) [5c]
1H NMR (400 MHz, CDCl3): 3.18 (s, 3 H), 4.60 (d, 1 H, J = 6.61 Hz), 4.98 (d, 1 H, J = 6.61
Hz), 7.14-7.32 (m, 10 H).
13C NMR (75 MHz, CDCl3): 57, 57.6, 87, 127.9, 128.1, 128.1, 128.2, 128.3, 128.8, 138.3,
138.7.
threo-1-Bromo-2-methoxy-1,2-diphenylethane (4p) [14]
1H NMR (300 MHz, CDCl3): 3.32 (s, 3 H), 4.45 (d, 1 H, J = 8.3 Hz), 4.94 (d, 1 H, J = 8.3 Hz),
6.98-7.40 (m, 10 H).
13C NMR (75 MHz, CDCl3): 57.2, 58.8, 87.4, 127.6, 128.1, 128.2, 128.5, 137.8, 138.8.
trans-2-Bromo-1-methoxyindane (4q) [5e]
1H NMR (300 MHz, CDCl3): 3.20 (m, 1 H), 3.56 (s, 3 H), 3.66 (m, 1 H), 4.38-4.46 (m, 1 H),
4.92 (d, 1 H, J = 3.58 Hz), 7.16-7.38 (m, 4 H).
13C NMR (75 MHz, CDCl3): 41.6, 50.7, 57.7, 91.7, 124.7, 125.2, 127.2, 129.1, 139.9, 140.4.
4-Bromo-3-methoxy-3-methylbutane-1-ol (4t) [13]
Chapter 4 Oxybromination
146
1H NMR (500 MHz, CDCl3): 1.35 (s, 3 H), 1.75-1.81 (m, 1 H), 1.97-2.04 (m, 1 H), 2.51 (bs, 1
H), 3.26 (s, 3 H), 3.39-3.45 (m, 2 H), 3.68-3.79 (m, 2 H).
2-Bromo-1-ethoxy-1-phenylethane (4A) [15]
1H NMR (300 MHz, CDCl3): 1.20 (t, 3 H), 3.38-3.51 (m, 4 H), 4.39-4.45 (dd, 1 H, J = 4.53,
8.30 Hz), 7.25-7.49 (m, 5 H).
13C NMR (75 MHz, CDCl3): 15.1, 36.5, 64.9, 81.6, 126.7, 128.3, 128.6, 139.8.
MS (EI, 70 eV): m/z (%) = 229 [M + 2]+ (10), 227 [M
+] (10), 135 (100), 121 (20), 107 (83), 91
(17), 77 (66), 51 (34).
2-Bromo-1-ethoxy-1-(4-methylphenyl)ethane (4C)
1H NMR (300 MHz, CDCl3): δ 1.20 (t, 3 H, J = 7.55, 14.35 Hz), 2.35 (s, 3 H), 3.32-3.52 (m, 2
H), 4.38 (dd, 1 H, J = 4.53, 7.55 Hz), 7.10-7.21 (m, 4 H).
13
C NMR (75 MHz, CDCl3): δ 15.1, 21.2, 36.6, 64.8, 81.4, 126.6, 129.2, 136.7, 138.1.
Anal.Calcd for C11H15BrO: C, 54.33; H, 6.21. Found: C, 53.95; H, 6.35.
2-Bromo-1-ethoxy-1-(2,4-dimethylphenyl)ethane (4D)
1H NMR (300 MHz, CDCl3): δ 1.20 (t, 3 H, J = 7.16 Hz), 2.29 (s, 3 H), 2.31 (s, 3 H), 3.30-3.46
(m, 4 H), 4.64 (dd, 1 H, J = 4.15, 8.49 Hz), 6.92 (s, 1 H), 6.98 (d, 1 H, J = 7.74 Hz), 7.25 (d, 1 H,
J = 7.74 Hz).
13C NMR (75 MHz, CDCl3): δ 15.1, 18.9, 20.9, 35.7, 64.7, 78.3, 125.9, 127, 131.3, 134.7, 135.3,
137.6.
MS (EI, 70 eV): m/z (%) = 258 [M + 2]+ (0.5), 256 [M
+] (0.5), 163 (100), 135 (47), 117 (22), 107
(56), 91 (30), 77 (12), 65 (5), 51 (4).
Anal. Calcd for C12H17BrO: C, 56.04; H, 6.66. Found: C, 56.14; H, 6.79.
2-Bromo-1-ethoxy-1-(4-t-butylphenyl)ethane (4E)
Chapter 4 Oxybromination
147
1H NMR (300 MHz, CDCl3): δ 1.20 (t, 3 H, J = 6.79 Hz), 1.32 (s, 9 H), 3.33-3.52 (m, 4 H), 4.4
(dd, 1 H, J = 4.53, 8.3 Hz), 7.20 (m, 2 H), 7.33 (m, 2 H).
13C NMR (75 MHz, CDCl3): δ 15.1, 31.3, 34.6, 36.7, 64.9, 81.4, 125.5, 126.3, 136.7, 151.3.
Anal. Calcd for C14H21BrO: C, 58.95; H, 7.42. Found: C, 59.25; H, 7.28.
2-Bromo-1-ethoxy-1-(4-chlorophenyl)ethane (4F)
1H NMR (300 MHz, CDCl3): δ 1.20 (t, 3 H), 3.30-3.50 (m, 4 H), 4.40 (dd, 1 H, J = 5.09, 7.55
Hz), 7.25 (d, 2 H, J = 8.49 Hz), 7.32 (d, 2 H, J = 8.49 Hz).
13C NMR (75 MHz, CDCl3): δ 15.1, 36.1, 65.1, 80.9, 128.1, 128.8, 134.1, 138.3.
Anal. Calcd for C10H12BrClO: C, 45.57; H, 4.58. Found: C, 45.32; H, 4.50.
2-Bromo-1-ethoxy-1-(4-bromophenyl)ethane (4G)
1H NMR (500 MHz, CDCl3): δ 1.20 (t, 3 H, J = 6.84, 13.69 Hz), 3.32-3.48 (m, 4 H), 4.38 (dd, 1
H, J = 4.89, 6.84 Hz), 7.20 (d, 2 H, J = 9 Hz), 7.48 (d, 2 H, J = 9 Hz).
13C NMR (75 MHz, CDCl3): δ 15.1, 36, 65.1, 81, 122.3, 128.4, 131.8, 138.8.
Anal. Calcd for C10H12Br2O: C, 38.99; H, 3.92. Found: C, 39.22; H, 3.71.
1-Bromo-2-ethoxy-2-phenylpropane (4H)
1H NMR (300 MHz, CDCl3): δ 1.19 (t, 3 H, J = 6.98 Hz), 1.69 (s, 3 H), 3.11-3.22 (m, 1 H), 3.29-
3.40 (m, 1 H), 3.45 (d, 1 H, J = 10.38 Hz), 3.57 (d, 1 H, J = 10.38 Hz), 7.20-7.40 (m, 5 H).
13C NMR (75 MHz, CDCl3): δ 15.6, 22.6, 43.1, 58.6, 77.6, 126.2, 127.6, 128.3, 142.5.
Anal. Calcd for C11H15BrO: C, 54.33; H, 6.21. Found: C, 54.16; H, 6.39.
1-Bromo-2-ethoxy-2-(4-chlorophenyl)propane (4I)
1H NMR (300 MHz, CDCl3): δ 1.18 (t, 3 H, J = 6.79, 13.59 Hz), 1.67 (s, 3 H), 3.08-3.54 (m, 4
H), 7.24-7.34 (m, 4 H).
13C NMR (75 MHz, CDCl3): δ 15.6, 22.5, 42.6, 58.7, 77.4, 127.7, 128.5, 133.6, 141.2.
Chapter 4 Oxybromination
148
Anal. Calcd for C11H14BrClO: C, 47.59; H, 5.08. Found: C, 47.87; H, 5.13.
erythro-2-Bromo-1-ethoxy-1-phenylpropanol (4J)
1H NMR (300 MHz, CDCl3): δ 1.20 (t, 3 H, J = 6.98 Hz), 2.71 (bs, 1 H), 3.40 (m, 2 H), 3.85-
4.04 (m, 2 H), 4.08-4.15 (m, 1 H), 4.53 (d, 1 H, J = 7.55 Hz), 7.25-7.38 (m, 5 H).
13C NMR (75 MHz, CDCl3): δ 15.1, 57.7, 64.9, 65.4, 84.7, 127.4, 128.4, 128.7, 138.9.
Anal. Calcd for C11H15BrO2: C, 50.98; H, 5.83. Found: C, 50.63; H, 5.71.
erythro-1-Bromo-2-ethoxy-1,2-diphenylethane (4O)
1H NMR (300 MHz, CDCl3): δ 1.08 (t, 3 H, J = 6.79, 14.35 Hz), 3.24-3.44 (m, 2 H), 4.68 (d, 1
H, J = 6.79 Hz), 4.92 (d, 1 H, J = 6.79 Hz), 7.14-7.32 (m, 10 H).
13C NMR (75 MHz, CDCl3): δ 15, 57.2, 65.3, 85.1, 127.7, 127.9, 128, 128.1, 128.1, 128.9, 138.7,
139.2.
Anal. Calcd for C16H17BrO: C, 62.96; H, 5.61. Found: C, 63.21; H, 5.76.
trans-2-Bromo-1-ethoxyindane (4Q) [15]
1H NMR (300 MHz, CDCl3): 1.25 (t, 3 H, J = 6.98 Hz), 3.19 (dd, 1 H, J = 5.09, 16.61 Hz),
3.60-3.92 (m, 3 H), 4.34-4.45 (m, 1 H), 5.00 (d, 1 H, J = 3.77 Hz), 7.12-7.38 (m, 4 H).
trans-2-Bromo-1-ethoxy-1-methylcyclohexane (4S)
1H NMR (300 MHz, CDCl3): δ 1.60 (t, 3 H, J = 6.79 Hz), 1.28 (s, 3 H), 1.35-1.85 (m, 7 H), 2.21-
2.32 (m, 1 H), 3.34-3.46 (m, 2 H), 4.15-4.20 (m, 1 H).
13C NMR (75 MHz, CDCl3): δ 16, 21.8, 23.3, 32.9, 33, 56.2, 60, 75.8.
Anal. Calcd for C9H17BrO: C, 48.88; H, 7.74. Found: C, 49.26; H, 7.62.
4-Bromo-3-ethoxy-3-methylbutane-1-ol (4T)
1H NMR (300 MHz, CDCl3): δ 1.19 (t, 3 H, J = 6.98 Hz), 1.37 (s, 3 H), 1.69-1.80 (m, 1 H), 1.98-
2.10 (m, 1 H), 3.36-3.54 (m, 4 H), 3.7-3.84 (m, 2 H).
Chapter 4 Oxybromination
149
13C NMR (75 MHz, CDCl3): δ 15.8, 21.5, 38.8, 38.9, 57.3, 59.2, 76.8.
Anal. Calcd for C7H15BrO2: C, 39.83; H, 7.16. Found: C, 39.91; H, 7.04.
1-Bromo-4-phenyl-3-butene-2-one (6) [16]
1H NMR (300 MHz, CDCl3): 4.01 (s, 2 H), 6.94 (d, 1 H, J = 16.05 Hz), 7.35-7.45 (m, 3 H),
7.53-7.61 (m, 2 H), 7.67 (d, 1 H, J = 16.05 Hz).
3-Bromo-4-ethoxy-4-phenylbutan-2-one (mixture of erythro and threo) (7)
1H NMR (300 MHz, CDCl3): 1.09 (t, 3 H, J = 6.98, 13.97 Hz, erythro), 1.20 (t, 3 H, J = 6.98,
13.97 Hz, threo), 2.17 (s, 3 H, threo), 2.40 (s, 3 H, erythro). 3.30-3.49 (m, 4 H, erythro+threo).
4.24 (d, 1 H, J = 9.63 Hz, erythro), 4.44 (d, 1 H, J = 7.55 Hz, threo), 4.61-4.69 (m, 2H,
erythro+threo), 7.30-7.45 (m, 10 H, erythro+threo).
13C NMR (75 MHz, CDCl3): δ 14.1, 14.9, 26.6, 28.4, 54.3, 57.8, 64.8, 65.2, 80.6, 82.1, 127.5,
127.8, 128.3, 128.5, 128.6, 137.7, 199.4, 200.9.
MS (EI, 70 eV): m/z (%) = 272 [M + 2]+ (10), 270 [M
+] (10), 191 (5), 135 (100), 91 (11), 77
(15), 51 (34).
Anal. Calcd for C12H15BrO2: C, 53.15; H, 5.58. Found: C, 53.24; H, 5.54.
2-Bromo-1-isopropoxy-1-phenylethane (Table 4.13, entry 6) [8c]
1H NMR (300 MHz, CDCl3): 1.09 (d, 3 H, J = 6.04 Hz), 1.21 (d, 3 H, J = 6.04 Hz), 3.33-3.48
(m, 2 H), 3.50-3.61 (m, 1 H), 4.52 (dd, 1 H, J = 4.53, 8.3 Hz), 7.25-7.35 (m, 5 H).
Chapter 4 Oxybromination
150
4.15. References
1. (a) E. Block, A. L. Schwan, In Comprehensive Organic Synthesis; B. M. Trost, I.
Fleming, M. F. Semmelhack, Eds.; Pergamon Press: Oxford, (1991) Vol.4, pp.344. (b) J.
Rodriguez, J. P. Dulcere, Synthesis, (1993) 1177. (c) A. Tenaglia, O. Pardigon, G. Buono,
J. Org. Chem., 61 (1996) 1129. (d) M. Haruyoshi, T. Kiyoshi, N. Masahiro, H. Akira, N.
Yutaka, I. Yasutaka, J. Org. Chem., 59 (1994) 5550.
2. (a) H. Sharghi, K. Niknam, M. Pooyan, Tetrahedron, 57 (2001) 6057. (b) J. G. Smith,
Fieser, M. Fieser and Fieser’s Reagent for Organic Synthesis; John Wiley and Sons:
New York, 1990; Vol 1-12. (c) G. Majelich, R. Hicks, S. Reister, J. Org. Chem., 62
(1997) 4321. (d) B. C. Ranu, S. Banerjee, J. Org. Chem., 70 (2005) 4517. (e) J. A.
Ciaccio, E. Heller, A. Talbot, Synlett, (1991) 248. (f) A. S. Cavallo, P. Lupattelli, C.
Bonini, J. Org. Chem., 70 (2005) 1605.
3. (a) D. R. Dalton, D. G. Jones, Tetrahedron Lett., 30 (1967) 2875. (b) J. S. Yadav, B. V.
S. Reddy, G. Baishya, S. J. Harshavardhan, Ch. J. Chary, M. K. Gupta, Tetrahedron Lett.,
46 (2005) 3569. (c) L. X. Shao, M. Shi, Synlett, (2006) 1269. (d) C. Chiappe, D. Capraro,
V. Conte, D. Pieraccini, Org. Lett., 3 (2001) 1061. (e) Comprehensive Organic
Transformations: A Guide to Functional Group Preparation, 2nd
ed.; R. C. Larock, Ed.;
Wiley-VCH: New York (1999); pp 629. (f) J. H. Rolston, K. Yates, J. Am. Chem. Soc.,
91 (1969) 1469. (g) R. P. Hanzlik, Organic Synthesis: Wiley & Sons: New York (1988)
Collect. Vol. 6, pp 560. (h) A. R. Chamberlin, M. Dezube, P. Dussalt, M. C. McMills, J.
Am. Chem. Soc., 105 (1983) 5819. (i) H. Masuda, K. Takase, M. Nishio, A. Hasegawa,
Y. Nishiyam, Y. Ishii, J. Org. Chem., 59 (1994) 5050. (j) B. Damin, J. Garapon, B.
Silion, Synthesis, (1981) 362.
Chapter 4 Oxybromination
151
4. (a) K. Yonchara, K. Kamata, K. Yamaguchi, N. Mizuno, Chem. Commun., 47 (2011)
1692. (b) T. Moriuchi, M. Yamaguchi, K. Kikushima, T. Hirao, Tetrahedron Lett., 48
(2007) 2667. (c) M. Yoshida, H. Mochizuki, T. Suzuki, N. Kamigata, Bull. Chem. Soc.
Jpn., 63 (1990) 3704. (d) G. W. Kabalka, K. Yang, N. K. Reddy, C. Narayana, Synth.
Commun., 28 (1998) 925.
5. (a) A. Podgorsek, M. Eissen, J. Fleckenstein, S. Stavber, M. Zupan, J. Iskra, Green
Chem., 11 (2009) 120. (b) N. Vijay, B. P. Sreeletha, A. Anu, G. G. Tesmol, T. Siji, M.
Vairamani, Tetrahedron, 57 (2001) 7417. (c) C. Ye, J. M. Shreeve, J. Org. Chem., 69
(2004) 856163. (d) B. F. Sels, D. E. De Vos, P. A. Jacobs, J. Am. Chem. Soc., 123 (2001)
8350. (e) G. Dewkar, S. V. Narina, A. Sudalai, Org. Lett., 5 (2003) 4501. (f) M. K.
Agarwal, S. Adimurthy, B. Ganguly, P. K. Ghosh, Tetrahedron, 65 (2009) 2791.
6. M. Zhu, S. Lin, G. L. Zhao, J. Sun, A. Cordova, Tetrahedron Lett., 51 (2010) 2708.
7. D. Urankar, I. Rutar, B. Modec, D. Dolenc, Eur. J. Org. Chem., (2005) 2349.
8. (a) K. Ma, S. Li, R. G. Weiss, Org. Lett., 10 (2008) 4155. (b) Y. Levin, K. Hamza, R.
Abu-Reziq, J. Blum, Eur. J. Org. Chem., (2006) 1396. (c) L. S. De Almeida, P. M.
Esteves, M. C. S. De Mattos, Synlett, (2006) 1515.
9. (a) M. A. Kumar, C. N. Rohitha, S. J. Kulkarni, N. Narender, Synthesis, (2010) 1629. (b)
N. Narender, K. V. V. K. Mohan, S. J. Kulkarni, K. V. Raghavan, J. Chem. Res (S).,
(2003) 597.
10. (a) P. Phukan, P. Chakraborty, D. Kataki, J. Org. Chem., 71 (2006) 7533. (b) J. B.
Langlois, A. Alexakis, Adv. Synth. Catal., 352 (2010) 447. (c) C. D. Roy, H. C. Brown,
J. Organomet. Chem., 692 (2007) 1608. (d) G. Steinfeld, V. Lozan, B. Kersting, Angew.
Chem., Int. Ed., 42 (2003) 2261. (e) T. N. Van, N. D. Kimpe, Tetrahedron, 59 (2003)
Chapter 4 Oxybromination
152
5941. (f) P. Lupattelli, C. Bonini, L. Caruso, A. Gambacorta, J. Org. Chem., 68 (2003)
3360.
11. S. D. Yang, Y. Shi, Z. H. Sun, Y. B. Zhaoa, Y. M. Liang, Tetrahedron: Asymmetry, 17
(2006) 1895.
12. G. Cerichelli, C. Grande, L. Luchetti, G. Mancini, J. Org. Chem., 56 (1991) 3025.
13. G. Gopalakrishnan, V. Kasinath, N. D. P. Singh, V. P. S. Krishnan, K. A. Solomon, S. S.
Rajan, Molecules, 7 (2002) 412.
14. M. F. Ruasse, G. L. Moro, B. Galland, R. Bianchini, C. Chiappe, G. Bellucci, J. Am.
Chem. Soc., 119 (1997) 12492.
15. J. Huet, Tetrahedron, 37 (1981) 731.
16. X. C. Li, D. Ferreira, M. R. Jacob, Q. Zhang, S. I. Khan, H. N. Elsohly, D. G. Nagle, T.
J. Smillie, I. A. Khan, L. A. Walker, A. M. Clark, J. Am. Chem. Soc., 126 (2004) 6872.
17. L. C. Vishwakarma, J. S. Walia, J. Indian Chem. Soc., 53 (1976) 156.